+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46308

Chapter 46308 provides scholary research titles of which PDF Full Texts are available through EurekaMag.

Voelker, R., 1997:
IHI views collaboration vs competition in quality. Institute for Healthcare Improvement

Grabeel, J., 1996:
IHPs revisited

Pallarito, K., 1993:
IHS CEO planning new nursing home company

Olesen, J., 1993:
IHS Classification: present and future

Saphir, A., 2000:
IHS expansion leads to Chapter 11

Anonymous, 2002:
IHS getting healthy returns in statewide diabetes initiative

Shriver, K., 1996:
IHS reports fourth-quarter shortfall

Doyle, J.M., 2000:
IHS takes over NovaCare's contract therapy business

Vickery, K., 2002:
IHS' reorganization plan taking shape

Nichol, D.K., 1984 :
IHSA Presidential Address 1984

Nicholls, R.M., 1983:
IHSA presidential address 1983

Anonymous, 1991:
IHSM (Institute of Health Services Management) membership

Jarrold, K.W., 1985:
IHSM Presidential Address 1985

Young, B., 1987:
IHSM Presidential Address 1987

Fletcher, S., 1991:
IHSM Presidential address: The challenge of change

Jarrold, K., 1985:
IHSM presidential address. A plain case for a good cause

Anonymous, 1997:
II AIOM National Conference on Colorectal Cancer. Milan, Italy, 10-11 March 1997

Amodeo, C.; Giorgi, D.M.; Mion, D.; Nobre, F.; Chaves Júnior, H.; Gomes, M.A.; Atie, C.S.; Pascoal, I.J.; Malachias, M.V.; Passaro, L.C.; Zanela, M.T.; Santelo, J.L.; Wajngarten, M.; Lima, E.G.; Ribeiro, J.M.; Jardim, P.C.; Lima Júnior, E.; Nascimento, R.; Introcaso, L.; Koch, V., 1998:
II Brazilian Consensus of Ambulatory Blood Pressure Monitoring

Cao, Y.; Wang, S.; Li, Y.; Chen, X.; Chen, L.; Wang, D.; Zhu, Z.; Yuan, Y.; Lv, D., 2018:
A method for screening active components from Chinese herbs by cell membrane chromatography-offline-high performance liquid chromatography/mass spectrometry and an online statistical tool for data processing

Santos Filho, R.D., 2001 :
II Brazilian consensus about dyslipidemia

Anonymous, 2001:
II Guidelines of the Brazilian Cardiology Society for acute myocardial infarct treatment. July 22 to 25 of 1999. Teresópolis-RJ

Anonymous, 2002:
II Guidelines on Ergometric Tests of the Brazilian Society of Cardiology

Anonymous, 1997:
II International Conference on the Elimination of Leprosy, New Delhi, 11-13 October 1996

Richardson, C.E.R.; Cunden, L.S.; Butty, V.L.; Nolan, E.M.; Lippard, S.J.; Shoulders, M.D., 2018:
A Method for Selective Depletion of Zn(II) Ions from Complex Biological Media and Evaluation of Cellular Consequences of Zn(II) Deficiency

Hepburn, E.; Northway, A.; Bekele, D.; Liu, G-Jun.; Currell, M., 2018:
A method for separation of heavy metal sources in urban groundwater using multiple lines of evidence

Hong, G.; Fu, T-Ming.; Qiao, M.; Viveros, R.D.; Yang, X.; Zhou, T.; Lee, J.Min.; Park, H-Gyu.; Sanes, J.R.; Lieber, C.M., 2018:
A method for single-neuron chronic recording from the retina in awake mice

Schreiber, D.K.; Perea, D.E.; Ryan, J.V.; Evans, J.E.; Vienna, J.D., 2018:
A method for site-specific and cryogenic specimen fabrication of liquid/solid interfaces for atom probe tomography

Tansukawat, N.D.; See, A.E.; Jiranuntirat, S.; Corbin, J.; Schomaker, J.M., 2018:
A Method for Small-Scale Production of Deuterochloroform

Roquette, J., 1994:
II Workshop on Gastroepiploic Artery for Myocardial Revascularization

Han, A., 2018:
A Method for Stereological Determination of the Structure Function From Histological Sections of Isotropic Scattering Media

Anonymous, 1999:
II nutritional status and life cycle issues

Tobin, N.H.; Woodward, C.; Zabih, S.; Lee, D.J.; Li, F.; Aldrovandi, G.M., 2018:
A Method for Targeted 16S Sequencing of Human Milk Samples

Chesnova, L.V., 2001:
II(XII) All-Russian Conference on Soil Zoology (November 15-19, 1999, Moscow)

Gough, D.B.; Heys, S.D.; Eremin, O., 1996:
II--Cancer cachexia: treatments strategies

Thurman, R.G., 1998:
II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin

Miller, S.J., 2000:
II. Biopsy techniques for suspected nonmelanoma skin cancers

Rosomoff, H.L.; Fishbain, D.A.; Cutler, R.B.; Steele-Rosomoff, R., 1995:
II. Do chronic pain patients' perceptions about their preinjury jobs differ as a function of worker compensation and non-worker compensation status?

Tsai, A.M.; van Zanten, J.H.; Betenbaugh, M.J., 1999:
II. Electrostatic effect in the aggregation of heat-denatured RNase A and implications for protein additive design

Koppang, R.; Berg, E.; Dahm, S.; Real, C.; Fløystrand, F., 1995:
A method for testing denture adhesives

Adler, J.; Raymond, J., 2001:
II. Fitness, nutrition, beauty. Fighting back, with sweat

Underwood, A., 2001:
II. Fitness, nutrition, beauty. More veggies, please

Tyre, P., 2001:
II. Fitness, nutrition, beauty. Turning back the clock

Springen, K., 2001:
II. Fitness, nutrition, beauty. What the nurses know

Rokyta, Z.; Racek, J.; Holecek, V.; Marik, J.J., 1998:
II. Free radicals and antioxidants in obstetrics

Williams-Hemby, L.; Porrino, L.J., 1998:
II. Functional consequences of intragastrically administered ethanol in rats as measured by the 2-[14C]deoxyglucose method: the contribution of dopamine

Tapiero, H.; Mathé, G.; Couvreur, P.; Tew, K.D., 2002:
II. Glutamine and glutamate

Jones, W.; Bellugi, U.; Lai, Z.; Chiles, M.; Reilly, J.; Lincoln, A.; Adolphs, R., 2000:
II. Hypersociability in Williams Syndrome

Anonymous, 1999:
II. Incidence and prevalence of ESRD

Jehn, U.; Dengler, R.; Petrides, P.E., 1996:
II. Leukemia in the elderly, secondary, recurrent and refractory leukemia, chloroma

Primus, R.J.; Thurkauf, A.; Xu, J.; Yevich, E.; McInerney, S.; Shaw, K.; Tallman, J.F.; Gallagher, D.W., 1997:
II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1

Anonymous, 2001:
II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000

Pilet, C., 1996:
II. On current state of knowledge concerning bovine spongiform encephalopathy (mad cow disease)

Andreasen, N.C.; O'Leary, D.S.; Cizadlo, T.; Arndt, S.; Rezai, K.; Watkins, G.L.; Ponto, L.L.; Hichwa, R.D., 1995:
II. PET studies of memory: novel versus practiced free recall of word lists

Isaacs, H., 2002:
II. Perinatal brain tumors: a review of 250 cases

Ruzyłło, E., 1995:
II. Physicians and their practice

Yamakawa, T.; Kotake, Y.; Fujitani, M.; Shintani, H.; Makino, Y.; Ohta, S., 2000:
II. Regional distribution in the brain of amines associated with Parkinson's disease

Alonso Gómez, A.M.; Paré Bardera, C.; Payá Serrano, R.; Placer Peralta, L.J.; San Román Calvar, J.A., 1997:
II. Role of Doppler echocardiography in the management of chronic ischemic cardiopathy

Rigotti, N.A., 2000:
II. Smoking cessation in the hospital setting-a new opportunity for managed care. Introduction

Manoj; Watson; Hibberd; Fillery-Travis; Robins, 1998:
II. Steady-State Rheological Investigations

Hazeldine, S.T.; Polin, L.; Kushner, J.; White, K.; Bouregeois, N.M.; Crantz, B.; Palomino, E.; Corbett, T.H.; Horwitz, J.P., 2002:
II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469)

Bonifacio, A.F., 1979:
II. The Institute of Health Sciences: a strategy for health manpower development

Shenfield, F.; Pennings, G.; Sureau, C.; Cohen, J.; Tarlatzis, B., 2001:
II. The cryopreservation of human embryos

Fenn, A-Marie., 2002:
II. The multiple art forms within the midwife: reflections from the 46th Annual ACNM Meeting and Exhibit. American College of Nurse-Midwives

Friol, J.P.; Chaise, F.; Gaisne, E., 1994:
II. The sequelae. Malunion of the distal end of the radius

Bewley, S.; Cockburn, J., 2002:
II. The unfacts of 'request' caesarean section

Worthington-Kirsch, R.L.; Andrews, R.T.; Siskin, G.P.; Shlansky-Goldberg, R.; Lipman, J.C.; Goodwin, S.C.; Bonn, J.; Hovsepian, D.M., 2002:
II. Uterine fibroid embolization: technical aspects

Grimaldi, A., 2003:
II. Vascular lesions in diabetics

Kochańska, I.; Nissen, I.; Marszal, J., 2018:
A method for testing the wide-sense stationary uncorrelated scattering assumption fulfillment for an underwater acoustic channel

Kondo, A.; Sakatani, M.; Tsuchiya, T.; Ogata, H.; Fujiwara, H.; Hara, H.; Yoneda, T.; Sato, K., 1996 :
II. multidisciplinary analysis of chronic excretors of Mycobacterium tuberculosis bacilli

Stubenitsky, B.M.; Booster, M.M.; Brasile, L.; Green, E.M.; Haisch, C.E.; Singh, H.K.; Jacobs, R.W.; Kootstra, G., 2000:
II: Ex vivo viability testing of kidneys after postmortem warm ischemia

McLellan, S.A.; Walsh, T.S.; McClellan, D.B.L., 2002:
II: Should we demand fresh red blood cells for perioperative and critically ill patients?

Mendenhall, C.L.; Roselle, G.A.; Grossman, C.J.; Gartside, P., 1998:
II: the effects of recombinant human insulin-like growth factor-1 on immunological recovery in the malnourished alcoholic rat

Surzhikov, V.D.; Fleĭshman, A.N., 2002:
III All-Russia Symposium on Slow Oscillatory Processes in the Human Body and Seminar on Nonlinear Dynamics in Physiology and Medicine. Novokuznestsk, May 21-25, 2001

Anonymous, 1993:
III Baltic Meeting on Pharmacology. Physiology and Pharmacology of the Respiratory System. Symposium proceedings. Copenhagen, Denmark, August 15-16, 1992

Santos, R.D., 2002:
III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia

Lazebnik, L.B.; Speranskiĭ, M.D.; Vostrikov, G.P.; Vasil'ev, I.V.; Il'chenko, A.A.; Il'chenko, L.Iu.; Komarov, B.D.; Kondashova, Z.D.; Parfenov, A.I., 2002:
III Congress of the Scientific Society of Russian Gastroenterologists and XXIX Scientific Session of the Central Research Institute of Gastroenterology of the Moscow Health Committee

Balestrieri, G.; Doria, A.; Galeazzi, M.; Meroni, P.L.; Migliorini, P.; Neri, R.; Tavoni, A.; Tincani, A.; Vitali, C.; Bombardieri, S., 1996:
III European Conference on Systemic Lupus Erythematosus. Conference summary

Vankipuram, A.; Traub, S.; Patel, V.L., 2018:
A method for the analysis and visualization of clinical workflow in dynamic environments

Anonymous, 1996:
III European Congress of Gerontology held at the RAI Conference Centre, Amsterdam, The Netherlands, 30 August-2 September 1995

Kim, U-Jung.; Kannan, K., 2018:
Method for the Determination of Iodide in Dried Blood Spots from Newborns by High Performance Liquid Chromatography Tandem Mass Spectrometry

Anonymous, 2001:
III Guidelines for the Use of Ambulatory Blood Pressure Monitoring - ambulatory monitoring of blood pressure. Sociedade Brasileira de Hipertensão

Bullard, W.; Kieft, R.; Sabatini, R., 2017:
A method for the efficient and selective identification of 5-hydroxymethyluracil in genomic DNA

Dufresne, J.; Florentinus-Mefailoski, A.; Bowden, P.; Marshall, J.G., 2018:
A method for the extraction of the endogenous tryptic peptides (peptidome) from human EDTA plasma

Arango, O.; Castillo, M., 2018:
A method for the inline measurement of milk gel firmness using an optical sensor

Angeletti, C., 2018:
A Method for the Interpretation of Flow Cytometry Data Using Genetic Algorithms

Anonymous, 1999:
III biochemical and clinical outcomes

Krailadsiri, P.; Seghatchian, M.J., 1999:
III-7 evaluation of IMAGN 2000: a new system for absolute leucocyte count

Soo; Huang; Ming; Kao; Munekata; Chang, 1996:
III-V diluted magnetic semiconductor: Substitutional doping of Mn in InAs

Andreoni, 1992:
III-V semiconductor microclusters: Structures, stability, and melting

Schmidt; Bechstedt; Srivastava, 1995:
III-V(110) surface dynamics from an ab initio frozen-phonon approach

Mikiel-Kostyra, K., 1996:
III. Barriers in breastfeeding: hyperbilirubinemia

Matsukawa, A.; Lukacs, N.W.; Hogaboam, C.M.; Chensue, S.W.; Kunkel, S.L., 2001:
III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung

Ostör, A.G.; Attwood, H.D.; Bettinger, H.F., 1998:
III. Dr. Hans Frederick Bettinger

Mills, D.L.; Alvarez, T.D.; S.G.orge, M.; Appelbaum, L.G.; Bellugi, U.; Neville, H., 2000:
III. Electrophysiological studies of face processing in Williams syndrome

Jones, B.E.; Czaja, M.J., 1998:
III. Intracellular signaling in response to toxic liver injury

Barker, D.C., 2000:
III. Maternal smoking cessation: a cost effective strategy for managed care. Introduction

Greenberg, S.H.; Springen, K., 2001:
III. Mind, moods and stress. Keeping hope alive

Underwood, A.; Watson, R., 2001:
III. Mind, moods and stress. Thanks for the memories

Blair, G., 2001:
III. Mind, moods and stress. The many faces I see

Anonymous, 2001:
III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000

Shigematsu, Y.; Korogi, Y.; Hirai, T.; Okuda, T.; Sugahara, T.; Liang, L.; Ge, Y.; Takahashi, M., 1998:
III. New developments: 2. Virtual MR endoscopy in the central nervous system

Ruzyłło, E., 1995:
III. Physicians and their practice

Simon, D., 2003:
III. Practical consequences of recent acquisitions in diabetes

Pachnis, V.; Durbec, P.; Taraviras, S.; Grigoriou, M.; Natarajan, D., 1998:
III. Role Of the RET signal transduction pathway in development of the mammalian enteric nervous system

Anonymous, 1999:
III. Treatment modalities for ESRD patients

Siskin, G.P.; Bonn, J.; Worthington-Kirsch, R.L.; Smith, S.J.; Shlansky-Goldberg, R.; Machan, L.S.; Andrews, R.T.; Goodwin, S.C.; Hovsepian, D.M., 2002:
III. Uterine fibroid embolization: pain management

Holcomb, B., 1978:
III. hospital rate setting board bill is signed

Anonymous, 1997:
IIIrd European Workshop on Digestive Surgery. Brussels, Belgium, 13-14 May 1997

Plotkin, B.J.; Davis, J.W.; Strizzi, L.; Lee, P.; Christoffersen-Cebi, J.; Kacmar, J.; Rivero, O.J.; Elsayed, N.; Zanghi, N.; Ito, B.; Sigar, I.M., 2018:
A method for the long-term cultivation of mammalian cells in the absence of oxygen: Characterization of cell replication, hypoxia-inducible factor expression and reactive oxygen species production

Bagavant, H.; Trzeciak, M.; Papinska, J.; Biswas, I.; Dunkleberger, M.L.; Sosnowska, A.; Deshmukh, U.S., 2018:
A Method for the Measurement of Salivary Gland Function in Mice

Swierkosz, T.A.; Valettas, N.; Herrmann, H.C., 2001:
IIb or not IIb: when, how, and which GP IIb/IIIa inhibitor?

Kereiakes, D.J.; Runyon, J.P.; Broderick, T.M.; Shimshak, T.M., 2000:
IIb's are not IIb's

Goryainova, O.S.; Ivanova, T.I.; Rutovskaya, M.V.; Tillib, S.V., 2017:
A Method for the Parallel and Sequential Generation of Single-Domain Antibodies for the Proteomic Analysis of Human Blood Plasma

Montalescot, G., 1999:
IIb/IIIa inhibitors in acute myocardial infarction

Parker, R.I., 2001:
IIb/IIIa or not IIb/IIIa, that is adhesion

Redwood, S., 2000:
IIb/IIIa or not IIb/IIIa? That is the question

Talley, J.D., 1996:
IIb/IIIa platelet inhibitors in the management of coronary artery disease

Palmer, R., 1975:
IInd European Endoscopy Congress

Hall, D.A.; Giraldo, Jús., 2018:
A method for the quantification of biased signalling at constitutively active receptors

Anonymous, 2001:
IJNP Calendar

Wang, J.; Morishima, S.; Okada, Y., 2002:
IK channels are involved in the regulatory volume decrease in human epithelial cells

Lohberger, B.; Groschner, K.; Tritthart, H.; Schreibmayer, W., 2001:
IK.ACh activation by arachidonic acid occurs via a G-protein-independent pathway mediated by the GIRK1 subunit

Kleber, A.G., 1994:
IK1 blockade as an antiarrhythmic mechanism

Rees, S.A.; Curtis, M.J., 1994:
IK1 blockade is a potentially useful antiarrhythmic mechanism

Opthof, T., 1994:
IK1 blockade is unlikely to be a useful antiarrhythmic mechanism

Malý, J., 2002:
IKEM (The Institute for Clinical and Experimental Medicine)--undergraduate and postgraduate education

DiDonato, J.A., 2001:
IKK alpha on center stage

Haller, D.; Russo, M.P.; Sartor, R.Balfour.; Jobin, C., 2002:
IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines

Regula, K.M.; Ens, K.; Kirshenbaum, L.A., 2002:
IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes

Li, X.; Massa, P.E.; Hanidu, A.; Peet, G.W.; Aro, P.; Savitt, A.; Mische, S.; Li, J.; Marcu, K.B., 2002:
IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program

Fisher, C., 2001:
IKKalpha-/- mice share phenotype with pupoid fetus (pf/pf) and repeated epilation (Er/Er) mutant mice

Yamamoto, Y.; Kim, D.W.; Kwak, Y.T.; Prajapati, S.; Verma, U.; Gaynor, R.B., 2001:
IKKgamma /NEMO facilitates the recruitment of the IkappaB proteins into the IkappaB kinase complex

Wolf, J.S.; Chen, Z.; Dong, G.; Sunwoo, J.B.; Bancroft, C.C.; Capo, D.E.; Yeh, N.T.; Mukaida, N.; Van Waes, C., 2001:
IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas

Kisner, H.J., 1991:
IL Monarch System--Instrumentation Laboratories

Li, J.; Farthing, P.M.; Ireland, G.W.; Thornhill, M.H., 1996:
IL-1 alpha and IL-6 production by oral and skin keratinocytes: similarities and differences in response to cytokine treatment in vitro

Shibuya, K.; Robinson, D.; Zonin, F.; Hartley, S.B.; Macatonia, S.E.; Somoza, C.; Hunter, C.A.; Murphy, K.M.; O'Garra, A., 1998:
IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice

Fouad, A.F., 1997:
IL-1 alpha and TNF-alpha expression in early periapical lesions of normal and immunodeficient mice

Joosten, L.A.; Helsen, M.M.; Saxne, T.; van D.L.o, F.A.; Heinegard, D.; van Den Berg, W.B., 1999:
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation

Kawaguchi, Y., 1994:
IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis

Speiser, P.; Zeillinger, R.; Wiltschke, C.; Sedlák, J.; Chorváth, B., 1993:
IL-1 alpha induced, TNF alpha mediated HLA class II (DR) antigen up-regulation in a human ductal breast carcinoma cell line ZR-75-1

Yamamoto, S.; Kamada, M.; Maegawa, M.; Takikawa, M.; Nakaya, Y.; Niwa, M.; Aono, T., 1997:
IL-1 alpha induces inducible nitric oxide synthase in uterine smooth muscle

Harmon, C.S.; Nevins, T.D., 1993:
IL-1 alpha inhibits human hair follicle growth and hair fiber production in whole-organ cultures

Bonifati, C.; Carducci, M.; Mussi, A.; D'auria, L.; Ameglio, F., 1998:
IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin

Nakae, S.; Naruse-Nakajima, C.; Sudo, K.; Horai, R.; Asano, M.; Iwakura, Y., 2001:
IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity

Knerer, B.; Hulla, W.; Martinek, H.; Formanek, M.; Temmel, A.; Kornfehl, J., 1996:
IL-1 and TNF-alpha but no IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR

Yamagishi, S.; Ohnishi, M.; Pawankar, R., 2000:
IL-1 and TNF-alpha-mediated regulation of IL-6, IL-8, and GM-CSF release from cultured nasal epithelial cells

Fagarasan, M.O.; Aisen, P.S., 1996:
IL-1 and anti-inflammatory drugs modulate A beta cytotoxicity in PC12 cells

Fauteux, L.J.; Osmond, D.G., 1996:
IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics

Siegmund, B.; Lehr, H.A.; Fantuzzi, G.; Dinarello, C.A., 2001:
IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation

Nylander-Lundqvist, E.; Bäck, O.; Egelrud, T., 1996:
IL-1 beta activation in human epidermis

Kelsen, S.G.; Anakwe, O.; Aksoy, M.O.; Reddy, P.J.; Dhanasekaran, N., 1997:
IL-1 beta alters beta-adrenergic receptor adenylyl cyclase system function in human airway epithelial cells

Li, Y.Y.; McTiernan, C.F.; Feldman, A.M., 1998:
IL-1 beta alters the expression of the receptor tyrosine kinase gene r-EphA3 in neonatal rat cardiomyocytes

Angel, J.; Audubert, F.; Bismuth, G.; Fournier, C., 1994:
IL-1 beta amplifies bradykinin-induced prostaglandin E2 production via a phospholipase D-linked mechanism

Wei, L.; Debets, R.; Hegmans, J.J.; Benner, R.; Prens, E.P., 1999:
IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production

Bessler, H.; Sirota, L.; Notti, I.; Dulitzky, F.; Djaldetti, M., 1993:
IL-1 beta and IL-3-like activity in preterm infants

Tanda, N.; Ohyama, H.; Yamakawa, M.; Ericsson, M.; Tsuji, T.; McBride, J.; Elovic, A.; Wong, D.T.; Login, G.R., 1998:
IL-1 beta and IL-6 in mouse parotid acinar cells: characterization of synthesis, storage, and release

Villiger, P.M.; Kusari, A.B.; ten Dijke, P.; Lotz, M., 1993:
IL-1 beta and IL-6 selectively induce transforming growth factor-beta isoforms in human articular chondrocytes

Machein, U.; Lieb, K.; Hüll, M.; Fiebich, B.L., 1995:
IL-1 beta and TNF alpha, but not IL-6, induce alpha 1-antichymotrypsin expression in the human astrocytoma cell line U373 MG

Song, H.; Saito, K.; Fujigaki, S.; Noma, A.; Ishiguro, H.; Nagatsu, T.; Seishima, M., 1998:
IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells

Tian, Z.; Shen, X.; Feng, H.; Gao, B., 2000:
IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway

Smith, D.J.; McGuire, M.J.; Tocci, M.J.; Thiele, D.L., 1997:
IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms

Fiorucci, S.; Santucci, L.; Cirino, G.; Mencarelli, A.; Familiari, L.; Soldato, P.D.; Morelli, A., 2000:
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs

Yang, F.; Jansen, L.; Friedrichs, W.E.; Buchanan, J.M.; Bowman, B.H., 1993:
IL-1 beta decreases expression of amyloid precursor protein gene in human glioma cells

Ogilvie, A.C.; Hack, C.E.; Wagstaff, J.; van Mierlo, G.J.; Erenberg, A.J.; Thomsen, L.L.; Hoekman, K.; Rankin, E.M., 1996:
IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer

Luft, T.; Jefford, M.; Luetjens, P.; Hochrein, H.; Masterman, K-Anne.; Maliszewski, C.; Shortman, K.; Cebon, J.; Maraskovsky, E., 2002:
IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation

Horie, H.; Sakai, I.; Akahori, Y.; Kadoya, T., 1997:
IL-1 beta enhances neurite regeneration from transected-nerve terminals of adult rat DRG

Mao, C.; Singh, A.K., 1996:
IL-1 beta gene expression in B cells derived from the murine MRL/lpr model of lupus

Patten, M.; Wang, W.; Aminololama-Shakeri, S.; Burson, M.; Long, C.S., 2000:
IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes

Bradford, P.G.; Maglich, J.M.; Kirkwood, K.L., 2000:
IL-1 beta increases type 1 inositol trisphosphate receptor expression and IL-6 secretory capacity in osteoblastic cell cultures

Tsuzaki, M.; Guyton, G.; Garrett, W.; Archambault, J.M.; Herzog, W.; Almekinders, L.; Bynum, D.; Yang, X.; Banes, A.J., 2003:
IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells

Wesa, A.K.; Galy, A., 2001:
IL-1 beta induces dendritic cells to produce IL-12

Homaidan, F.R.; Zhao, L.; Burakoff, R., 1997 :
IL-1 beta induces synthesis of phospholipase A2-activating protein in rabbit distal colon

Bird, J.L.; Wells, T.; Platt, D.; Bayliss, M.T., 1997:
IL-1 beta induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide

Odoux, C.; Crestani, B.; Lebrun, G.; Rolland, C.; Aubin, P.; Fournier, T.; Fiet, J.; Aubier, M., 1997:
IL-1 beta inhibits ET-1 production by ATII cells in vitro: evidence for involvement of cyclooxygenase 2 pathway

Rohn, W.; Tang, L.P.; Dong, Y.; Benveniste, E.N., 1999:
IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene

Delikat, S.; Harris, R.J.; Galvani, D.W., 1993:
IL-1 beta inhibits adipocyte formation in human long-term bone marrow culture

Clarke, D.J.; Branton, R.L., 2002:
IL-1 beta is released from the host brain following transplantation but does not compromise embryonic dopaminergic neuron survival

Yin, L.; Li, L.; Pan, Y.; Tan, Y.; He, A., 2003:
IL-1 beta mRNA and TNF-alpha mRNA expression in gingival tissues of patients with adult periodontitis

Tokoro, Y.; Yamamoto, T.; Hara, K., 1996:
IL-1 beta mRNA as the predominant inflammatory cytokine transcript: correlation with inflammatory cell infiltration into human gingiva

Faggioni, R.; Fantuzzi, G.; Fuller, J.; Dinarello, C.A.; Feingold, K.R.; Grunfeld, C., 1998:
IL-1 beta mediates leptin induction during inflammation

Linner, K.M.; Nicol, S.E.; Sharp, B.M., 1993:
IL-1 beta modulates the concanavalin-A-induced expression of proenkephalin A mRNA in murine thymocytes

Obreja, O.; Rathee, P.K.; Lips, K.S.; Distler, C.; Kress, M., 2002:
IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C

Raber, J.; Pich, E.M.; Koob, G.F.; Bloom, F.E., 1994:
IL-1 beta potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala

Brandolini, L.; Bertini, R.; Bizzarri, C.; Sergi, R.; Caselli, G.; Zhou, D.; Locati, M.; Sozzani, S., 1996:
IL-1 beta primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux

Brooks, C.J.; King, W.J.; Radford, D.J.; Adu, D.; McGrath, M.; Savage, C.O., 1996:
IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis

Kühn, K.; Hashimoto, S.; Lotz, M., 2000:
IL-1 beta protects human chondrocytes from CD95-induced apoptosis

Brand, C.U.; Hunziker, T.; Yawalkar, N.; Braathen, L.R., 1996:
IL-1 beta protein in human skin lymph does not discriminate allergic from irritant contact dermatitis

Hirata, F.; Lee, J.Y.; Sakamoto, T.; Nomura, A.; Uchida, Y.; Hirata, A.; Hasegawa, S., 1994:
IL-1 beta regulates the expression of the Gi2 alpha gene via lipid mediators in guinea pig tracheal muscle

Hastie, A.T.; Everts, K.B.; Cho, S.K.; Zangrilli, J.; Shaver, J.R.; Pollice, M.B.; Fish, J.E.; Peters, S.P., 1996:
IL-1 beta release from cultured bronchial epithelial cells and bronchoalveolar lavage cells from allergic and normal humans following segmental challenge with ragweed

Srivastava, S.K.; Tetsuka, T.; Daphna-Iken, D.; Morrison, A.R., 1994:
IL-1 beta stabilizes COX II mRNA in renal mesangial cells: role of 3'-untranslated region

Boota, A.; Zar, H.; Kim, Y.M.; Johnson, B.; Pitt, B.; Davies, P., 1996:
IL-1 beta stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells

Vassiliadis, S.; Soteriadou, K.P.; Papadopoulos, G.K., 1997:
IL-1 beta transduces different signals than IL-1 alpha leading to class II antigen expression on beta-insulinoma RIN-5AH cells through specific receptors

Wong, M.L.; Bongiorno, P.B.; al-Shekhlee, A.; Esposito, A.; Khatri, P.; Licinio, J., 1996:
IL-1 beta, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areas

Bessler, H.; Djaldetti, R.; Salman, H.; Bergman, M.; Djaldetti, M., 1999:
IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease

Keenan, J.A.; Chen, T.T.; Chadwell, N.L.; Torry, D.S.; Caudle, M.R., 1995:
IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis

Yung, S.; Coles, G.A.; Davies, M., 1996:
IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD

Kehlen, A.; Lauterbach, R.; Santos, A.N.; Thiele, K.; Kabisch, U.; Weber, E.; Riemann, D.; Langner, J., 2001:
IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA)

Wewers, M.D.; Dare, H.A.; Winnard, A.V.; Parker, J.M.; Miller, D.K., 1998:
IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent

Ayala, J.M.; Yamin, T.T.; Egger, L.A.; Chin, J.; Kostura, M.J.; Miller, D.K., 1994:
IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor

Xie, J.F.; Stroumza, J.; Graves, D.T., 1994:
IL-1 down-regulates platelet-derived growth factor-alpha receptor gene expression at the transcriptional level in human osteoblastic cells

Feloutzis, A.; Lang, N.P.; Tonetti, M.S.; Bürgin, W.; Brägger, U.; Buser, D.; Duff, G.W.; Kornman, K.S., 2003:
IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population

Reinhardt, R.A.; Masada, M.P.; Johnson, G.K.; DuBois, L.M.; Seymour, G.J.; Allison, A.C., 1993:
IL-1 in gingival crevicular fluid following closed root planing and papillary flap debridement

Camacho, M.; Godessart, N.; Vila, L., 1997:
IL-1 increases the ability of human endothelial cells to transform linoleic acid into monohydroxy-isomers and their incorporation into cell lipids

Gabay, C., 2000:
IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis

Aime, C.; Bristol, L.; Cohen-Kaminsky, S.; Berrih-Aknin, S.; Durum, S.; Takács, L., 1993:
IL-1 mRNA expression detected by in situ hybridization and polymerase chain reaction in human thymus and thymoma. Correlation with late T-cell maturation in normal versus neoplastic thymus

Thom, A.K.; Fraker, D.L.; Norton, J.A., 1993:
IL-1 receptor antagonist (IL-1ra) augments IL-2-induced pulmonary vascular leak

Thompson, R.C., 1993 :
IL-1 receptor antagonist in arthritis and arthritis models

Swantek, J.L.; Tsen, M.F.; Cobb, M.H.; Thomas, J.A., 2001:
IL-1 receptor-associated kinase modulates host responsiveness to endotoxin

Weng, J.; Mohan, R.R.; Li, Q.; Wilson, S.E., 1997:
IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 beta expression in the cornea

O'Neill, L., 2001:
IL-1 versus TNF in arthritis?

Allam, A.F.; Osman, M.M.; el-Sayed, M.H.; Demian, S.R., 2001:
IL-1, IL-4 production and IgE levels in acute and chronic fasciolosis before and after triclabendazole treatment

Li, X.; Commane, M.; Jiang, Z.; Stark, G.R., 2001:
IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)

Chao, C.C.; Lokensgard, J.R.; Sheng, W.S.; Hu, S.; Peterson, P.K., 1997:
IL-1-induced iNOS expression in human astrocytes via NF-kappa B

Lacey, D.L.; Grosso, L.E.; Moser, S.A.; Erdmann, J.; Tan, H.L.; Pacifici, R.; Villareal, D.T., 1993:
IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3

Origuchi, T.; Migita, K.; Nakashima, T.; Tominaga, M.; Nakamura, H.; Nakashima, M.; Aoyagi, T.; Kawakami, A.; Kawabe, Y.; Eguchi, K., 2000:
IL-1-mediated expression of membrane type matrix-metalloproteinase in rheumatoid osteoblasts

Press, R.; Deretzi, G.; Zou, L.P.; Zhu, J.; Fredman, P.; Lycke, J.; Link, H., 2000:
IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group

Pousset, F.; Cremona, S.; Dantzer, R.; Kelley, K.W.; Parnet, P., 2001:
IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes

Carrington, L.; McLeod, D.; Boulton, M., 2001:
IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction

Volk, H.; Asadullah, K.; Gallagher, G.; Sabat, R.; Grutz, G., 2001:
IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets

Smith, E.M.; Cadet, P.; Stefano, G.B.; Opp, M.R.; Hughes, T.K., 2000:
IL-10 as a mediator in the HPA axis and brain

Stearns, M.E.; Wang, M.; Stearns, M., 1995:
IL-10 blocks collagen IV invasion by "invasion stimulating factor" activated PC-3 ML cells: upregulation of TIMP-1 expression

Bosshardt, S.C.; Freeman, G.L.; Secor, W.E.; Colley, D.G., 1997:
IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni

Gollnick, S.O.; Musser, D.A.; Oseroff, A.R.; Vaughan, L.; Owczarczak, B.; Henderson, B.W., 2002:
IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response

Park, D.R.; Skerrett, S.J., 1996:
IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages

el-Malky, B.S.; Soliman, M.; Mageid, A.A.; el-Nemr, H.E.; el-Nashar, E.M.; Hawas, S., 2002 :
IL-10 gene expression as a marker for detection of protective immunity levels with irradiated cercarial vaccine against experimental Schistosoma mansoni infection

Book, A.A.; Fielding, K.E.; Kundu, N.; Wilson, M.A.; Fulton, A.M.; Laterra, J., 1999:
IL-10 gene transfer to intracranial 9L glioma: tumor inhibition and cooperation with IL-2

Otsuki, T.; Yata, K.; Sakaguchi, H.; Uno, M.; Fujii, T.; Wada, H.; Sugihara, T.; Ueki, A., 2002:
IL-10 in myeloma cells

Blackstone, M.O., 2001:
IL-10 in post ERCP pancreatitis

Dieu-Nosjean, M.C.; Massacrier, C.; Vanbervliet, B.; Fridman, W.H.; Caux, C., 2001:
IL-10 induces CCR6 expression during Langerhans cell development while IL-4 and IFN-gamma suppress it

Romano, M.F.; Lamberti, A.; Petrella, A.; Bisogni, R.; Tassone, P.F.; Formisano, S.; Venuta, S.; Turco, M.C., 1996:
IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes

Buelens, C.; Willems, F.; Piérard, G.; Delvaux, A.; Velu, T.; Goldman, M., 1995:
IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells

Allen, E.M.; Luzina, I.G.; Huang, S.K., 2001:
IL-10 kinetics in thyroiditis-prone BB/Wor rats

Viana da Costa, A.; Huerre, M.; Delacre, M.; Auriault, C.; Correia Costa, Jé.Manuel.; Verwaerde, C., 2002:
IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection

Allavena, P.; Piemonti, L.; Longoni, D.; Bernasconi, S.; Stoppacciaro, A.; Ruco, L.; Mantovani, A., 1997:
IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran

Egle, A.; Marschitz, I.; Posch, B.; Herold, M.; Greil, R., 1996:
IL-10 serum levels in B-cell chronic lymphocytic leukaemia

Stelmach, I.; Jerzyńska, J.; Bobrowska, M.; Brzozowska, A.; Majak, Pł.; Kuna, P., 2002:
IL-10 serum levels in children with moderate asthma

Morinobu, A.; Kumagai, S.; Yanagida, H.; Ota, H.; Ishida, H.; Matsui, M.; Yodoi, J.; Nakao, K., 1996:
IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes

Herfarth, H.; Schölmerich, J., 2002:
IL-10 therapy in Crohn's disease: at the crossroads. Treatment of Crohn's disease with the anti-inflammatory cytokine interleukin 10

Rouleau, M.; Cottrez, F.; Bigler, M.; Antonenko, S.; Carballido, J.M.; Zlotnik, A.; Roncarolo, M.G.; Groux, H., 1999:
IL-10 transgenic mice present a defect in T cell development reminiscent of SCID patients

Osman, M.M.; Abo-El-Nazar, S.Y., 2003:
IL-10, IFN-gamma and TNF-alpha in acute and chronic human fascioliasis

Lehmann, J.; Seegert, D.; Strehlow, I.; Schindler, C.; Lohmann-Matthes, M.L.; Decker, T., 1994:
IL-10-induced factors belonging to the p91 family of proteins bind to IFN-gamma-responsive promoter elements

Clarke, C.J.; Hales, A.; Hunt, A.; Foxwell, B.M., 1998:
IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity

Wang, M.; Hu, Y.; Shima, I.; Stearns, M.E., 2002 :
IL-10/IL-10 receptor signaling regulates TIMP-1 expression in primary human prostate tumor lines

Terkeltaub, R.A., 1999:
IL-10: An "immunologic scalpel" for atherosclerosis?

Borish, L., 1998:
IL-10: evolving concepts

Dams-Kozlowska, H.; Izycki, D.; Mackiewicz, A., 2002:
IL-11 is a potent anti-melanoma factor

Nadler; Stanford; Zhang; Upperman; Ford, 2000:
IL-11 is upregulated in human NEC

Trepicchio, W.L.; Wang, L.; Bozza, M.; Dorner, A.J., 1998:
IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB

Grohmann, U.; Bianchi, R.; Belladonna, M.L.; Vacca, C.; Silla, S.; Ayroldi, E.; Fioretti, M.C.; Puccetti, P., 1999:
IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo

Horvath-Arcidiacono, J.A.; Mostowski, H.S.; Bloom, E.T., 1996:
IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-gamma

Trembleau, S.; Gregori, S.; Penna, G.; Gorny, I.; Adorini, L., 2001:
IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule

Ponti, C.; Falconi, M.; Billi, A.Maria.; Faenza, I.; Castorina, S.; Caimi, L.; Cacchioli, A.; Cocco, L.; Vitale, M., 2001:
IL-12 and IL-15 induce activation of nuclear PLCbeta in human natural killer cells

Barbulescu, K.; Becker, C.; Schlaak, J.F.; Schmitt, E.; Meyer zum Büschenfelde, K.H.; Neurath, M.F., 1998:
IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes

Verma, V.; Sharma, V.; Shrivastava, S.K.; Nadkarni, J.J., 2001:
IL-12 and IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients

Komastu, T.; Ireland, D.D.; Reiss, C.S., 1999:
IL-12 and viral infections

Scott, P.; Trinchieri, G., 1997:
IL-12 as an adjuvant for cell-mediated immunity

Schwarting, A.; Tesch, G.; Kinoshita, K.; Maron, R.; Weiner, H.L.; Kelley, V.R., 1999:
IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice

Rotman, H.L.; Schnyder-Candrian, S.; Scott, P.; Nolan, T.J.; Schad, G.A.; Abraham, D., 1997:
IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis

Xu, H.; Kurihara, H.; Ito, T.; Nakajima, S.; Hagiwara, E.; Yamanokuchi, H.; Asari, A., 2001:
IL-12 enhances lymphoaccumulation by suppressing cell death of T cells in MRL- lpr/lpr mice

Anonymous, 2001:
IL-12 for hepatitis C

Tahara, H.; Lotze, M.T.; Robbins, P.D.; Storkus, W.J.; Zitvogel, L., 1995:
IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts

Yang, J.; Qian, Q.; Xue, H.; Cao, H.; Cui, Z.; Shi, W.; Yang, G.; Wu, M., 2002:
IL-12 gene treatment of hepatocellular carcinoma: experimental study

Hall, S.S., 1994:
IL-12 holds promise against cancer, glimmer of AIDS hope

Sinigaglia, F., 2000:
IL-12 in lung diseases

Horiuchi, Y.; Nishioka, K., 2002:
IL-12 in varicella zoster and herpes simplex virus infection

Puddu, P.; Fantuzzi, L.; Borghi, P.; Varano, B.; Rainaldi, G.; Guillemard, E.; Malorni, W.; Nicaise, P.; Wolf, S.F.; Belardelli, F.; Gessani, S., 1997:
IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages

Windhagen, A.; Anderson, D.E.; Carrizosa, A.; Williams, R.E.; Hafler, D.A., 1996:
IL-12 induces human T cells secreting IL-10 with IFN-gamma

Kawamoto, K.; Paliwal, V.; Ramabhadran, R.; Szczepanik, M.; Tsuji, R.F.; Matsuda, H.; Askenase, P.W., 1999:
IL-12 is produced by antigen-presenting cells stimulated with soluble alphabeta TCR and restores impaired T(h)1 responses

Anonymous, 2002:
IL-12 may be useful for hepatitis C

Kozar, K.; Kaminski, R.; Giermasz, A.; Basak, G.; Zagozdzon, R.; Rybczynska, J.; Wasik, M.; Lasek, W.; Jakobisiak, M.; Golab, J., 2002:
IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells

Kichian, K.; Nestel, F.P.; Kim, D.; Ponka, P.; Lapp, W.S., 1996 :
IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma

Lucas, M.Lee.; Heller, L.; Coppola, D.; Heller, R., 2002:
IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma

Szeliga, J.; Hess, H.; Rüde, E.; Schmitt, E.; Germann, T., 1996:
IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis

Kawakami, K.; Tohyama, M.; Xie, Q.; Saito, A., 1996:
IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans

Igarashi, O.; Yamane, H.; Imajoh-Ohmi, S.; Nariuchi, H., 1998:
IL-12 receptor (IL-12R) expression and accumulation of IL-12R beta 1 and IL-12R beta 2 mRNAs in CD4+ T cells by costimulation with B7-2 molecules

Roy, E.J.; Gawlick, U.; Orr, B.A.; Rund, L.A.; Webb, A.G.; Kranz, D.M., 2000:
IL-12 treatment of endogenously arising murine brain tumors

Yoshimoto, T.; Takeda, K.; Tanaka, T.; Ohkusu, K.; Kashiwamura, S.; Okamura, H.; Akira, S.; Nakanishi, K., 1998:
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production

Gans, H.A.; Maldonado, Y.; Yasukawa, L.L.; Beeler, J.; Audet, S.; Rinki, M.M.; DeHovitz, R.; Arvin, A.M., 1999:
IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants

Torigo, S.; Ihara, T.; Kamiya, H., 2001:
IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella

Tchórzewski, H.; Krasomski, G.; Biesiada, L.; Głowacka, E.; Banasik, M.; Lewkowicz, P., 2001:
IL-12, IL-6 and IFN-gamma production by lymphocytes of pregnant women with rheumatoid arthritis remission during pregnancy

Lim, Y.C.; Xie, H.; Come, C.E.; Alexander, S.I.; Grusby, M.J.; Lichtman, A.H.; Luscinskas, F.W., 2001:
IL-12, STAT4-dependent up-regulation of CD4(+) T cell core 2 beta-1,6-n-acetylglucosaminyltransferase, an enzyme essential for biosynthesis of P-selectin ligands

Davidson, N.J.; Hudak, S.A.; Lesley, R.E.; Menon, S.; Leach, M.W.; Rennick, D.M., 1998:
IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice

Hong, K.; Chu, A.; Lúdvíksson, B.R.; Berg, E.L.; Ehrhardt, R.O., 1999:
IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder

Geldhof, A.B.; Moser, M.; D.B.etselier, P., 1999:
IL-12-activated NK cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells

Hussell, T.; Openshaw, P.J., 2000:
IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions

Magram, J.; Sfarra, J.; Connaughton, S.; Faherty, D.; Warrier, R.; Carvajal, D.; Wu, C.Y.; Stewart, C.; Sarmiento, U.; Gately, M.K., 1996:
IL-12-deficient mice are defective but not devoid of type 1 cytokine responses

Magram, J.; Connaughton, S.E.; Warrier, R.R.; Carvajal, D.M.; Wu, C.Y.; Ferrante, J.; Stewart, C.; Sarmiento, U.; Faherty, D.A.; Gately, M.K., 1996:
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses

L.H.r, M.; Ryffel, B.; Schatzmann, U., 2001 :
IL-12-dependent, INF-gamma-independent experimental glomerulonephritis

Zitvogel, L.; Couderc, B.; Mayordomo, J.I.; Robbins, P.D.; Lotze, M.T.; Storkus, W.J., 1996:
IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo

Müller, U.; Köhler, G.; Mossmann, H.; Schaub, G.A.; Alber, G.; D.S.nto, J.P.; Brombacher, F.; Hölscher, C., 2001:
IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18

Xing, Z.; Zganiacz, A.; Wang, J.; Divangahi, M.; Nawaz, F., 2000:
IL-12-independent Th1-type immune responses to respiratory viral infection: requirement of IL-18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive Th1-type lymphocytes

Takeuchi, E.; Yanagawa, H.; Suzuki, Y.; Shinkawa, K.; Ohmoto, Y.; Bando, H.; Sone, S., 2002:
IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions

Poggi, A.; Zocchi, M.R.; Costa, P.; Ferrero, E.; Borsellino, G.; Placido, R.; Galgani, S.; Salvetti, M.; Gasperini, C.; Ristori, G.; Brosnan, C.F.; Battistini, L., 1999:
IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients

Ozenci, V.; Pashenkov, M.; Kouwenhoven, M.; Rinaldi, L.; Söderström, M.; Link, H., 2001:
IL-12/IL-12R system in multiple sclerosis

Stober, D.; Schirmbeck, R.; Reimann, J., 2001:
IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells

Wigginton, J.M.; Wiltrout, R.H., 2002:
IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside

Abdi, K., 2002:
IL-12: the role of p40 versus p75

Bailer, R.T.; Holloway, A.; Sun, J.; Margolick, J.B.; Martin, M.; Kostman, J.; Montaner, L.J., 1999:
IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression

Rosenwasser, L.J., 2000:
IL-13 genetics: pale rider or horse of a different color?

Corry, D.B., 2000:
IL-13 in allergy: home at last

Lopez, M.; Amorim, L.; Gane, P.; Cristoph, A.; Bardinet, D.; Abina, A.M.; Minty, A.; Bernard, J., 1998:
IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells

Mattes, J.; Yang, M.; Siqueira, A.; Clark, K.; MacKenzie, J.; McKenzie, A.N.; Webb, D.C.; Matthaei, K.I.; Foster, P.S., 2001:
IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung

Sozzani, P.; Hasan, L.; Séguélas, M.H.; Caput, D.; Ferrara, P.; Pipy, B.; Cambon, C., 1998:
IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production

Hoshino, T.; Winkler-Pickett, R.T.; Mason, A.T.; Ortaldo, J.R.; Young, H.A., 1999:
IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma

Muchamuel, T.; Menon, S.; Pisacane, P.; Howard, M.C.; Cockayne, D.A., 1997:
IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production

Kim, C-Hoon.; Song, K.Seob.; Koo, J.Seok.; Kim, H-Ung.; Cho, J.Young.; Kim, H.Jun.; Yoon, J-Heon., 2002:
IL-13 suppresses MUC5AC gene expression and mucin secretion in nasal epithelial cells

Manna, S.K.; Aggarwal, B.B., 1998:
IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis

Urban, J.; Fang, H.; Liu, Q.; Ekkens, M.J.; Chen, S.J.; Nguyen, D.; Mitro, V.; Donaldson, D.D.; Byrd, C.; Peach, R.; Morris, S.C.; Finkelman, F.D.; Schopf, L.; Gause, W.C., 2001:
IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive

Asadullah, K.; Haeussler-Quade, A.; Gellrich, S.; Hanneken, S.; Hansen-Hagge, T.E.; Döcke, W.D.; Volk, H.D.; Sterry, W., 2000:
IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression

Mueller, Y.M.; Bojczuk, P.M.; Halstead, E.Scott.; Kim, A.H.J.; Witek, J.; Altman, J.D.; Katsikis, P.D., 2002:
IL-15 enhances survival and function of HIV-specific CD8+ T cells

Mueller, Y.M.; Makar, V.; Bojczuk, P.M.; Witek, J.; Katsikis, P.D., 2002:
IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells

García, V.E.; Jullien, D.; Song, M.; Uyemura, K.; Shuai, K.; Morita, C.T.; Modlin, R.L., 1998:
IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens

Weng, N-Ping.; Liu, K.; Catalfamo, M.; Li, Y.; Henkart, P.A., 2003:
IL-15 is a growth factor and an activator of CD8 memory T cells

Nishimura, H.; Hiromatsu, K.; Kobayashi, N.; Grabstein, K.H.; Paxton, R.; Sugamura, K.; Bluestone, J.A.; Yoshikai, Y., 1996:
IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection

Losy, J.; Niezgoda, A.; Zaremba, Jław., 2003:
IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis

Avice, M.N.; Demeure, C.E.; Delespesse, G.; Rubio, M.; Armant, M.; Sarfati, M., 1998:
IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation

Lai, Y.G.; Gelfanov, V.; Gelfanova, V.; Kulik, L.; Chu, C.L.; Jeng, S.W.; Liao, N.S., 1999:
IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes

Plunkett, F.J.; Akbar, A.N., 2001:
IL-15--friend or foe in transplantation rejection?

Ohta, N.; Hiroi, T.; Kweon, M-Na.; Kinoshita, N.; Jang, M.Ho.; Mashimo, T.; Miyazaki, J-Ichi.; Kiyono, H., 2002:
IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation

Pereno, R.; Gaggero, A.; Scudeletti, M.; Lanza, L.; Meazza, R.; Mishal, Z.; Jasmin, C.; Indiveri, F.; Ferrini, S.; Azzarone, B., 1999:
IL-15/IL-15R alpha intracellular trafficking in human cells and protection from apoptosis

Tagaya, Y.; Bamford, R.N.; DeFilippis, A.P.; Waldmann, T.A., 1996:
IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels

Viglianti, G.A.; Parada, N.A.; Maciaszek, J.W.; Kornfeld, H.; Center, D.M.; Cruikshank, W.W., 1997:
IL-16 anti-HIV-1 therapy

Chabaud, M.; Lubberts, E.; Joosten, L.; van Den Berg, W.; Miossec, P., 2001 :
IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

Hsieh, H.G.; Loong, C.C.; Lui, W.Y.; Chen, A.; Lin, C.Y., 2001:
IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection

Albanesi, C.; Cavani, A.; Girolomoni, G., 1999:
IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha

Witowski, J.; Pawlaczyk, K.; Breborowicz, A.; Scheuren, A.; Kuzlan-Pawlaczyk, M.; Wisniewska, J.; Polubinska, A.; Friess, H.; Gahl, G.M.; Frei, U.; Jörres, A., 2000:
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells

Jovanovic, D.V.; D.B.ttista, J.A.; Martel-Pelletier, J.; Jolicoeur, F.C.; He, Y.; Zhang, M.; Mineau, F.; Pelletier, J.P., 1998:
IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages

Bohn, E.; Sing, A.; Zumbihl, R.; Bielfeldt, C.; Okamura, H.; Kurimoto, M.; Heesemann, J.; Autenrieth, I.B., 1998:
IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice

Tsutsui, H.; Matsui, K.; Kawada, N.; Hyodo, Y.; Hayashi, N.; Okamura, H.; Higashino, K.; Nakanishi, K., 1997:
IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice

Kalina, U.; Kauschat, D.; Koyama, N.; Nuernberger, H.; Ballas, K.; Koschmieder, S.; Bug, G.; Hofmann, W.K.; Hoelzer, D.; Ottmann, O.G., 2000:
IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21

Walker, W.; Aste-Amezaga, M.; Kastelein, R.A.; Trinchieri, G.; Hunter, C.A., 1999 :
IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma

Kashiwamura, S.; Okamura, H., 1998:
IL-18 and IL-18 receptor

Bossù, P.; Del Giudice, E.; Ciaramella, A.; Neumann, D.; Boraschi, D., 2001:
IL-18 and IL-18 receptors in the development of autoimmunity

Nakanishi, K.; Tsutsui, H.; Yoshimoto, T., 2003:
IL-18 and atopic inflammation

Kawakami, K.; Koguchi, Y.; Qureshi, M.H.; Miyazato, A.; Yara, S.; Kinjo, Y.; Iwakura, Y.; Takeda, K.; Akira, S.; Kurimoto, M.; Saito, A., 2000:
IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells

Shi, F.D.; Takeda, K.; Akira, S.; Sarvetnick, N.; Ljunggren, H.G., 2000:
IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells

Lauw, F.N.; Branger, J.; Florquin, S.; Speelman, P.; van Deventer, S.J.H.; Akira, S.; van der Poll, T., 2001:
IL-18 improves the early antimicrobial host response to pneumococcal pneumonia

Losy, J.; Niezgoda, A., 2001:
IL-18 in patients with multiple sclerosis

Tokmadzić, V.S.; Tsuji, Y.; Bogović, T.; Laskarin, G.; Cupurdija, K.; Strbo, N.; Koyama, K.; Okamura, H.; Podack, E.R.; Rukavina, D., 2003:
IL-18 is present at the maternal-fetal interface and enhances cytotoxic activity of decidual lymphocytes

Blease, K.; Kunkel, S.L.; Hogaboam, C.M., 2002:
IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2

Kawakami, K.; Qureshi, M.H.; Zhang, T.; Okamura, H.; Kurimoto, M.; Saito, A., 1998:
IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production

Faggioni, R.; Cattley, R.C.; Guo, J.; Flores, S.; Brown, H.; Qi, M.; Yin, S.; Hill, D.; Scully, S.; Chen, C.; Brankow, D.; Lewis, J.; Baikalov, C.; Yamane, H.; Meng, T.; Martin, F.; Hu, S.; Boone, T.; Senaldi, G., 2001:
IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice

Suska, F.; Esposito, M.; Gretzer, C.; Källtorp, M.; Tengvall, P.; Thomsen, P., 2002:
IL-1alpha, IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with titanium and copper

Rühl, A.; Franzke, S.; Stremmel, W., 2001:
IL-1beta and IL-10 have dual effects on enteric glial cell proliferation

Maass, D.L.; White, J.; Horton, J.W., 2002:
IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma

Kelles, A.; Janssens, J.; Tack, J., 2000:
IL-1beta and IL-6 excite neurones and suppress cholinergic neurotransmission in the myenteric plexus of the guinea pig

Yokoo, T.; Kitamura, M., 1997:
IL-1beta depresses expression of the 70-kilodalton heat shock protein and sensitizes glomerular cells to oxidant-initiated apoptosis

Noguchi, T.; Noguchi, M.; Masubuchi, H.; Seki, T.; Ariga, T., 2001:
IL-1beta down-regulates tissue-type plasminogen activator by up-regulating low-density lipoprotein receptor-related protein in AML 12 cells

Ogura, N.; Tobe, M.; Tamaki, H.; Nagura, H.; Abiko, Y., 2002:
IL-1beta increases uPA and uPA receptor expression in human gingival fibroblasts

Parikh, A.A.; Moon, M.R.; Pritts, T.A.; Fischer, J.E.; Szabó, C.; Hasselgren, P.O.; Salzman, A.L., 2000:
IL-1beta induction of NF-kappaB activation in human intestinal epithelial cells is independent of oxyradical signaling

Grutkoski, P.S.; D'Amico, R.; Ayala, A.; Simms, H.H., 1999:
IL-1beta stimulation induces paracrine regulation of PMN function and apoptosis

Jablonska, E.; Jablonski, J.; Piotrowski, L.; Grabowska, Z., 2002:
IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC and the serum levels in patients with inflammation and patients with cancer disease of the same location

Osiri, M.; Ruxrungtham, K.; Nookhai, S.; Ohmoto, Y.; Deesomchok, U., 1999:
IL-1beta, IL-6 and TNF-alpha in synovial fluid of patients with non-gonococcal septic arthritis

Neumann, D.; Lienenklaus, S.; Rosati, O.; Martin, M.U., 2003:
IL-1beta-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1

Vincent, J.L.; Slotman, G.; Van Leeuwen, P.A.; Shelly, M.; Nasraway, S.; Tenaillon, A.; Bander, J.; Friedman, G., 1999:
IL-1ra administration does not improve cardiac function in patients with severe sepsis

Heesen, C.; Sieverding, F.; Buhmann, C.; Gbadamosi, J., 2000:
IL-1ra serum levels in disease stages of MS--a marker for progression?

Marsh, C.B.; Moore, S.A.; Pope, H.A.; Wewers, M.D., 1994:
IL-1ra suppresses endotoxin-induced IL-1 beta and TNF-alpha release from mononuclear phagocytes

Hong, M.A.; Wakim, V.L.; Salomão, S.J.; Camargo, L.S.; Casseb, J.; Duarte, A.J., 1999:
IL-2 and IFN-gamma, but not IL-4 secretion by peripheral blood mononuclear cells (PBMC) are related to CD4+ T cells and clinical status in Brazilian HIV-1-infected subjects

Sírová, M.; Ríhová, B.; Ríha, I.; Leipner, C., 1993:
IL-2 and IL-3 production in high and low IgG-responding strains of mice

Nishizawa, K.; Koyasu, S., 1997:
IL-2 and IL-7 differentially induce CD4-CD8- alpha beta TCR+NK1.1+ large granular lymphocytes and IL-4-producing cells from CD4-CD8- alpha beta TCR+NK1.1- cells: implications for the regulation of Th1- and Th2-type responses

Sharief, M.K., 1993:
IL-2 and MS

Chyczewska, E.; Mróz, R.M.; Kowal, E., 1997:
IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients

Bathe, O.F.; Dalyot-Herman, N.; Malek, T.R., 2001:
IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells

Highleyman, L., 2001:
IL-2 flushes out HIV

Sterritt, C., 2001:
IL-2 for HIV: the long march toward FDA approval. Food and Drug Administration

Liu, S.; Lin, Y.; Tang, S.; Yang, H.; Liang, C., 2003:
IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma

Stein, U.; Walther, W.; Shoemaker, R.H.; Schlag, P.M., 1999 :
IL-2 gene transfer for chemosensitization of multidrug-resistant human colon carcinoma cells

Indrová, M.; Pajtasz-Piasecka, E.; Jandlová, T.; Símová, J.; Bubeník, J.; Radzikowski, C., 2000:
IL-2 gene-modified tumour vaccines: monitoring of IL-2 levels in serum and peritoneal cavity of vaccinated mice

Guarini, A.; Gansbacher, B.; Cronin, K.; Fierro, M.T.; Foa, R., 1995:
IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response

Lissoni, P.; Bucovec, R.; Meregalli, S.; Fumagalli, L.; Vigorè, L.; Ferrante, R.; Brivio, F., 1999:
IL-2 immunotherapy-induced increase in IL-12 blood concentrations may depend on an increase in circulating dendritic cell number

Atzpodien, J.; Kirchner, H.; Illiger, H.J.; Metzner, B.; Ukena, D.; Schott, H.; Funke, P.J.; Gramatzki, M.; Jürgenson, S.; Wandert, T.; Patzelt, T.; Reitz, M., 2001:
IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

Wang, K.S.; Ritz, J.; Frank, D.A., 1999:
IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells

Nielsen, M.; Svejgaard, A.; Skov, S.; Dobson, P.; Bendtzen, K.; Geisler, C.; Odum, N., 1996:
IL-2 induces beta2-integrin adhesion via a wortmannin/LY294002-sensitive, rapamycin-resistant pathway. Phosphorylation of a 125-kilodalton protein correlates with induction of adhesion, but not mitogenesis

Anonymous, 1997:
IL-2 injections boost CD4 cells

Smith, K.A., 2001:
IL-2 low dose and treatment interruption: interview with Kendall A. Smith. Interview by John S. James

Anonymous, 2001:
IL-2 plus HAART reduces HIV in immune system "hiding places"

Rayon, C., 1997:
IL-2 post-autologous transplant of hematopoietic stem cells

Demaison, C.; Fiette, L.; Blanchetière, V.; Schimpl, A.; Thèze, J.; Froussard, P., 1998:
IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs

McIntosh, R.S.; Tandon, N.; Pickerill, A.P.; Davies, R.; Barnett, D.; Weetman, A.P., 1993:
IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease. Analysis of V alpha transcript microheterogeneity

Rinfret, A.; Anderson, S.K., 1993:
IL-2 regulates the expression of the NK-TR gene via an alternate RNA splicing mechanism

Grodeck, B., 1995:
IL-2 restores immune sytem

Gómez, J.; García, A.; R-Borlado, L.; Bonay, P.; Martínez-A.C.; Silva, A.; Fresno, M.; Carrera, A.C.; Eicher-Streiber, C.; Rebollo, A., 1997:
IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta

Anonymous, 2001:
IL-2 study results in confusion

Anonymous, 2001:
IL-2 study web site available

Gilden, D., 2001:
IL-2 taken to HAART

Grundström, S.; Dohlsten, M.; Sundstedt, A., 2000:
IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor

Anonymous, 1997:
IL-2 update

Anonymous, 2001:
IL-2 without antiretroviral therapy, trial near Wash. D.C

Lin, J.; Li, L.; Gao, Y.; Min, B.; Xu, X., 1997:
IL-2, IFN-gamma, and TNF-alpha mRNA expression in peripheral blood mononuclear cells in patients with multiple sclerosis

Li, Y.; Chen, B.; Qiu, C.C., 1996:
IL-2, IL-2R mRNA gene expression and protein production

Royuela, M.; D.M.guel, M.P.; Bethencourt, F.R.; Fraile, B.; Arenas, M.I.; Paniagua, R., 2000:
IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis

Su, H.C.; Orange, J.S.; Fast, L.D.; Chan, A.T.; Simpson, S.J.; Terhorst, C.; Biron, C.A., 1994:
IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice

Agostini, M.; D.M.rco, B.; Spinicelli, S.; Bruscoli, S.; Delfino, D.V., 2002:
IL-2-driven natural killer cell generation: role of anti-H-2b monoclonal antibodies and stromal cells in controlling quantitative and repertoire changes

Iacobelli, M.; Rohwer, F.; Shanahan, P.; Quiroz, J.A.; McGuire, K.L., 1999:
IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells

Robinet, E.; Fournel, S.; Fatmi, A.; Revillard, J.P., 1996:
IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering

Frucht, D.M., 2002:
IL-23: a cytokine that acts on memory T cells

Fort, M.M.; Cheung, J.; Yen, D.; Li, J.; Zurawski, S.M.; Lo, S.; Menon, S.; Clifford, T.; Hunte, B.; Lesley, R.; Muchamuel, T.; Hurst, S.D.; Zurawski, G.; Leach, M.W.; Gorman, D.M.; Rennick, D.M., 2002:
IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo

James, J.S., 1996:
IL-2: controlled trial finds major CD4 increases

Eicher, D.M.; Waldmann, T.A., 1998:
IL-2R alpha on one cell can present IL-2 to IL-2R beta/gamma(c) on another cell to augment IL-2 signaling

Eckenberg, R.; Moreau, J.L.; Melnyk, O.; Thèze, J., 2000:
IL-2R beta agonist P1-30 acts in synergy with IL-2, IL-4, IL-9, and IL-15: biological and molecular effects

Phillips, K.E.; Herring, B.; Wilson, L.A.; Rickford, M.S.; Zhang, M.; Goldman, C.K.; Tso, J.Y.; Waldmann, T.A., 2001:
IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction

Porter, B.O.; Malek, T.R., 1999:
IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development

Chen, Q.; Solar, G.; Eaton, D.L.; de Sauvage, F.J., 2000:
IL-3 does not contribute to platelet production in c-Mpl-deficient mice

Crooks, G.M.; Hao, Q.L.; Petersen, D.; Barsky, L.W.; Bockstoce, D., 2000:
IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells

Antoku, K.; Liu, Z.; Johnson, D.E., 1998:
IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells

Ackermann, L.W.; Wollenweber, L.A.; Denning, G.M., 1999:
IL-4 and IFN-gamma increase steady state levels of polymeric Ig receptor mRNA in human airway and intestinal epithelial cells

Hofman, T., 1995:
IL-4 and IFN-gamma level in blood serum of children with food allergy

van Den Broek, M.; Bachmann, M.F.; Köhler, G.; Barner, M.; Escher, R.; Zinkernagel, R.; Kopf, M., 1999:
IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2

Poe, J.C.; Wagner, D.H.; Miller, R.W.; Stout, R.D.; Suttles, J., 1997:
IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis

Palmer-Crocker, R.L.; Hughes, C.C.; Pober, J.S., 1996:
IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain

Hatzistilianou, M.; Aggouridaki, C.; Catriu, D.; Athanassiadou, F., 1996:
IL-4 and SCD23 in children with atopic dermatitis

Wadhwa, M.; Dilger, P.; Meager, A.; Walker, B.; Gaines-Das, R.; Thorpe, R., 1996:
IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF

Trompezinski, S.; Denis, A.; Vinche, A.; Schmitt, D.; Viac, J., 2002:
IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts

Nogawa, S., 1996:
IL-4 and tumor immunity

Coyle, A.J.; Bertrand, C.; Tsuyuki, S.; Pircher, H.; Walti, S.; L.G.os, G.; Erard, F., 1996:
IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma

Cluitmans, F.H.; Esendam, B.H.; Landegent, J.E.; Willemze, R.; Falkenburg, J.H., 1994:
IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes

Wang, H.Y.; Paul, W.E.; Keegan, A.D., 1996:
IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain

Benedetti, S.; D.M.co, F.; Cirenei, N.; Bruzzone, M.G.; Pollo, B.; Florio, N.; Caposio, L.; Colombo, M.P.; Cattaneo, E.; Finocchiaro, G., 1999:
IL-4 gene transfer for the treatment of experimental gliomas

Fu, J.; Li, C.; Yang, X.; Li, X., 2000:
IL-4 gene transfer induces the differentiation of cells and inhibits the activity of telomerase in hepatoblastoma cells

Lingnau, K.; Hoehn, P.; Kerdine, S.; Koelsch, S.; Neudoerfl, C.; Palm, N.; Ruede, E.; Schmitt, E., 1998:
IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12

Pearce, E.J.; Vasconcelos, J.P.; Brunet, L.R.; Sabin, E.A., 1996:
IL-4 in schistosomiasis

Jourdan, P.; Abbal, C.; Noraz, N.; Hori, T.; Uchiyama, T.; Vendrell, J.P.; Bousquet, J.; Taylor, N.; Pène, J.; Yssel, H.; Nora, N., 1998:
IL-4 induces functional cell-surface expression of CXCR4 on human T cells

Wick, K.R.; Berton, M.T., 2001:
IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes

Ryan, J.J.; DeSimone, S.; Klisch, G.; Shelburne, C.; McReynolds, L.J.; Han, K.; Kovacs, R.; Mirmonsef, P.; Huff, T.F., 1998:
IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism

Bendixen, A.C.; Shevde, N.K.; Dienger, K.M.; Willson, T.M.; Funk, C.D.; Pike, J.W., 2001:
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1

Levings, M.K.; Schrader, J.W., 1999:
IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms

Spinozzi, F.; Nicoletti, I.; Agea, E.; Belia, S.; Moraca, R.; Migliorati, G.; Riccardi, C.; Grignani, F.; Bertotto, A., 1995:
IL-4 is able to reverse the CD2-mediated negative apoptotic signal to CD4-CD8- alpha beta and/or gamma delta T lymphocytes

Sugawara, I.; Yamada, H.; Mizuno, S.; Iwakura, Y., 2001:
IL-4 is required for defense against mycobacterial infection

Szalay, G.; Ladel, C.H.; Blum, C.; Kaufmann, S.H., 1996:
IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice

Bian, Z.M.; Elner, S.G.; Strieter, R.M.; Kunkel, S.L.; Lukacs, N.W.; Elner, V.M., 1999:
IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells

Emoto, M.; Emoto, Y.; Kaufmann, S.H., 1995:
IL-4 producing CD4+ TCR alpha beta int liver lymphocytes: influence of thymus, beta 2-microglobulin and NK1.1 expression

Tori, M.; Ito, T.; Yumiba, T.; Ohkawa, A.; Maeda, A.; Sawai, T.; Kiyomoto, T.; Akamaru, Y.; Miyasaka, M.; Kiyono, H.; Matsuda, H.; Nozawa, M.; Shirakura, R., 1999:
IL-4 production in IDDM-nonrecurrent pancreas-transplanted BB rats with donor-derived NKR-P1+TCR alpha beta + (NKT) cells, but not in IDDM-recurrent BB rats

Cohn, L.; Herrick, C.; Niu, N.; Homer, R.; Bottomly, K., 2001:
IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation

Aguirre, S.A.; Perryman, L.E.; Davis, W.C.; McGuire, T.C., 1998:
IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection

Brunet, L.R.; Finkelman, F.D.; Cheever, A.W.; Kopf, M.A.; Pearce, E.J., 1997:
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis

Launois, P.; Maillard, I.; Pingel, S.; Swihart, K.G.; Xénarios, I.; Acha-Orbea, H.; Diggelmann, H.; Locksley, R.M.; MacDonald, H.R.; Louis, J.A., 1997:
IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice

Schnarr, B.; Ezernieks, J.; Sebald, W.; Duschl, A., 1997:
IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins

Pan, P.Y.; Rothman, P., 2000:
IL-4 receptor mutations

Ting, C.C.; Liang, S.M.; Wang, J.; Chen, Y.Y.; Hargrove, M.; Xu, N., 1994:
IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells

Flesch, I.E.; Wandersee, A.; Kaufmann, S.H., 1997:
IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis

Losman, J.; Chen, X.P.; Jiang, H.; Pan, P.Y.; Kashiwada, M.; Giallourakis, C.; Cowan, S.; Foltenyi, K.; Rothman, P., 2001:
IL-4 signaling is regulated through the recruitment of phosphatases, kinases, and SOCS proteins to the receptor complex

Nies, J.H.; Bär, C.; Schlenvoigt, G.; Fahlbusch, B.; Zwacka, G.; Markert, U.R., 2002:
IL-4 supplemented B-cell cultures of allergic children show reduced IgA and IgG production in response to additional stimulation with IL-10

Ihn, H.; Yamane, K.; Asano, Y.; Kubo, M.; Tamaki, K., 2002:
IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway

Terada, N.; Konno, A.; Terada, Y.; Fukuda, S.; Yamashita, T.; Abe, T.; Shimada, H.; Ishida, K.; Yoshimura, K.; Tanaka, Y., 1995:
IL-4 upregulates Fc epsilon RI alpha-chain messenger RNA in eosinophils

Joyce, D.A.; Steer, J.H., 1996:
IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes

Szczepanik, A.M.; Funes, S.; Petko, W.; Ringheim, G.E., 2001:
IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line

Young, D.A.; Lowe, L.D.; Booth, S.S.; Whitters, M.J.; Nicholson, L.; Kuchroo, V.K.; Collins, M., 2000:
IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis

Caproni, M.; Calzolari, A.; Giomi, B.; Santucci, M.; Ficarra, G.; Fabbri, P., 2002:
IL-4, IL-5, TGF-beta1 and IFN-gamma mRNAs detected by a new in situ amplification system in cicatricial pemphigoid

Kakinuma, T.; Nakamura, K.; Wakugawa, M.; Yano, S.; Saeki, H.; Torii, H.; Komine, M.; Asahina, A.; Tamaki, K., 2002:
IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line

Nguyen, V.T.; Benveniste, E.N., 2000:
IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia

Aronica, M.A.; Goenka, S.; Boothby, M., 2000:
IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway

Elovic, A.E.; Ohyama, H.; Sauty, A.; McBride, J.; Tsuji, T.; Nagai, M.; Weller, P.F.; Wong, D.T., 1998:
IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils

Cohn, L.; Tepper, J.S.; Bottomly, K., 1998:
IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells

Ohmori, Y.; Hamilton, T.A., 1998:
IL-4-induced STAT6 suppresses IFN-gamma-stimulated STAT1-dependent transcription in mouse macrophages

Song, G.Y.; Chung, C.S.; Chaudry, I.H.; Ayala, A., 2000:
IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis

Bronte, V.; Serafini, P.; D.S.nto, C.; Marigo, I.; Tosello, V.; Mazzoni, A.; Segal, D.M.; Staib, C.; Lowel, M.; Sutter, G.; Colombo, M.P.; Zanovello, P., 2002:
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

Sanz, M.J.; Marinova-Mutafchieva, L.; Green, P.; Lobb, R.R.; Feldmann, M.; Nourshargh, S., 1998:
IL-4-induced eosinophil accumulation in rat skin is dependent on endogenous TNF-alpha and alpha 4 integrin/VCAM-1 adhesion pathways

Schwaiger, S.; Wolf, A.Maria.; Robatscher, P.; Jenewein, B.; Grubeck-Loebenstein, B., 2002:
IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age

Gerber, D.J.; Azuara, V.; Levraud, J.P.; Huang, S.Y.; Lembezat, M.P.; Pereira, P., 1999:
IL-4-producing gamma delta T cells that express a very restricted TCR repertoire are preferentially localized in liver and spleen

Lawrence, C.E.; Paterson, J.C.; Higgins, L.M.; MacDonald, T.T.; Kennedy, M.W.; Garside, P., 1998:
IL-4-regulated enteropathy in an intestinal nematode infection

Jiang, H.; Harris, M.B.; Rothman, P., 2000:
IL-4/IL-13 signaling beyond JAK/STAT

Kotsimbos, A.T.; Hamid, Q., 1997:
IL-5 and IL-5 receptor in asthma

Martin, C.; Al-Qaoud, K.M.; Ungeheuer, M.N.; Paehle, K.; Vuong, P.N.; Bain, O.; Fleischer, B.; Hoerauf, A., 2001:
IL-5 is essential for vaccine-induced protection and for resolution of primary infection in murine filariasis

Sampson, A.P., 2001:
IL-5 priming of eosinophil function in asthma

Kopf, M.; Brombacher, F.; Hodgkin, P.D.; Ramsay, A.J.; Milbourne, E.A.; Dai, W.J.; Ovington, K.S.; Behm, C.A.; Köhler, G.; Young, I.G.; Matthaei, K.I., 1996:
IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses

Hamelmann, E.; Gelfand, E.W., 2001:
IL-5-induced airway eosinophilia--the key to asthma?

Weltman, J.K.; Karim, A.S., 2000:
IL-5: biology and potential therapeutic applications

Wysocki, P.J.; Kowalczyk, D.W.; Izycki, D.; Grabarczyk, P.; Kwias, Z.; Mackiewicz, A., 2002:
IL-6 and GM-CSF in tumor rejection model of renal cell cancer

Kozak, W.; Kluger, M.J.; Soszynski, D.; Conn, C.A.; Rudolph, K.; Leon, L.R.; Zheng, H., 1999:
IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice

Horton, S.B.; Butt, W.W.; Mullaly, R.J.; Thuys, C.A.; O'Connor, E.B.; Byron, K.; Cochrane, A.D.; Brizard, C.P.; Karl, T.R., 1999:
IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating

Ferrà, C.; de Sanjosé, S.; Gallardo, D.; Berlanga, J.J.; Rueda, F.; Marìn, D.; de la Banda, E.; Ancìn, I.; Peris, J.; Garcìa, J.; Grañena, A., 1999:
IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation

Kaplanski, G.; Teysseire, N.; Farnarier, C.; Kaplanski, S.; Lissitzky, J.C.; Durand, J.M.; Soubeyrand, J.; Dinarello, C.A.; Bongrand, P., 1995:
IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway

Holzheimer, R.G.; Molloy, R.G.; Görlach, H.; Wilkert, S.; Hehrlein, F., 1994:
IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery

Pałczyński, B.; Chełmońska-Soyta, A.; Zimecki, M.; Banach, E., 2002 :
IL-6 and TNF-alpha levels in oviductal epithelial cells culture after escherichia coli LPS stimulation

Yoshizaki, K., 1998:
IL-6 and autoimmune diseases

Senior, K., 1999:
IL-6 and gp130 signalling: its role in chronic disease

Stelmasiak, Z.; Kozioł-Montewka, M.; Dobosz, B.; Rejdak, K., 2001:
IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients

D.P.i, E.; Ferraccioli, G.F., 1999:
IL-6 and some natural inhibitors of chronic human inflammation in RA and SLE

Kong, B.; Isozaki, T.; Sasaki, S., 1996:
IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism

Armario, A.; Hernández, J.; Bluethmann, H.; Hidalgo, J., 1999:
IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6

Xie, P.; Chan, F.S.; Ip, N.Y.; Leung, M.F., 2000:
IL-6 enhanced the retinoic acid-induced differentiation of human acute promyelocytic leukemia cells

Kikuchi, T.; Ishida, S.; Kinoshita, T.; Sakuma, S.; Sugawara, N.; Yamashita, T.; Koike, K., 2003:
IL-6 enhances IgE-dependent histamine release from human peripheral blood-derived cultured mast cells

Zhong, H.; Gu, F.; Yu, L., 1996:
IL-6 gene expression in human tumor cell lines

Song, L.; Li, Y.; Sun, Y-xun.; Yu, M.; Shen, B-fen., 2002:
IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1

Grohmann, U.; Fallarino, F.; Bianchi, R.; Belladonna, M.L.; Vacca, C.; Orabona, C.; Uyttenhove, C.; Fioretti, M.C.; Puccetti, P., 2001:
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase

Kurtiş, B.; Develioğlu, H.; Taner, I.L.; Baloş, K.; Tekin, I.O., 2000:
IL-6 levels in gingival crevicular fluid (GCF) from patients with non-insulin dependent diabetes mellitus (NIDDM), adult periodontitis and healthy subjects

Bitounis, D.; Barnier, V.; Guibert, C.; Pourchez, Jérémie.; Forest, Vérie.; Boudard, D.; Hochepied, J-François.; Chelle, P.; Vergnon, J-Michel.; Cottier, Mèle., 2018:
A method for the quantitative extraction of gold nanoparticles from human bronchoalveolar lavage fluids through a glycerol gradient

Hokland, P.; Mikkelsen, P.; Segel, E., 1994:
IL-6 might relieve long-standing thrombocytopenia in autotransplanted AML patients

Parikh, A.A.; Salzman, A.L.; Kane, C.D.; Fischer, J.E.; Hasselgren, P.O., 1997:
IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B

Gonzalez-Gay, M.A.; Hajeer, A.H.; Dababneh, A.; Garcia-Porrua, C.; Mattey, D.L.; Amoli, M.M.; Thomson, W.; Ollier, W.E.R., 2002:
IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis

Graf, M.R.; Prins, R.M.; Merchant, R.E., 2000:
IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity

Barton, B.E.; Murphy, T.F.; Adem, P.; Watson, R.A.; Irwin, R.J.; Huang, H.F., 2001:
IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells

Puthier, D.; Bataille, R.; Amiot, M., 1999:
IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway

James, K.; Premchand, N.; Skibinska, A.; Skibinski, G.; Nicol, M.; Mason, J.I., 1997:
IL-6, DHEA and the ageing process

Cao, Q.; Batey, R.; Pang, G.; Russell, A.; Clancy, R., 1999:
IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A

Clavien, P.A., 1997:
IL-6, a key cytokine in liver regeneration

Alvino, S.; Marcucci, M.; Canzoniere, D.; Mosiello, A.; Del Monte, G.; Venturo, I.; Rinaldi, M.; Gandolfo, G.M.; Lopez, M.; Greco, C., 1999:
IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias

Murakami, M.; Hibi, M.; Nakagawa, N.; Nakagawa, T.; Yasukawa, K.; Yamanishi, K.; Taga, T.; Kishimoto, T., 1993:
IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase

Akira, S., 1998:
IL-6-regulated transcription factors

Levison, S.W.; Jiang, F.J.; Stoltzfus, O.K.; Ducceschi, M.H., 2000:
IL-6-type cytokines enhance epidermal growth factor-stimulated astrocyte proliferation

Kaplanski, G.; Marin, Vérie.; Montero-Julian, Félix.; Mantovani, A.; Farnarier, C., 2002:
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

Kitazawa, H.; Muegge, K.; Badolato, R.; Wang, J.M.; Fogler, W.E.; Ferris, D.K.; Lee, C.K.; Candéias, S.; Smith, M.R.; Oppenheim, J.J.; Durum, S.K., 1997:
IL-7 activates alpha4beta1 integrin in murine thymocytes

Tsark, E.C.; Dao, M.A.; Wang, X.; Weinberg, K.; Nolta, J.A., 2000:
IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice

Toraldo, G.; Roggia, C.; Qian, W-Ping.; Pacifici, R.; Weitzmann, M.Neale., 2002:
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells

Verhoeyen, E.; Dardalhon, V.; Ducrey-Rundquist, O.; Trono, D.; Taylor, N.; Cosset, Fçois-Loïc., 2002:
IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes

Fry, T.J.; Moniuszko, M.; Creekmore, S.; Donohue, S.J.; Douek, D.C.; Giardina, S.; Hecht, T.T.; Hill, B.J.; Komschlies, K.; Tomaszewski, J.; Franchini, G.; Mackall, C.L., 2002:
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates

Okamoto, Y.; Douek, D.C.; McFarland, R.D.; Koup, R.A., 2002:
IL-7, the thymus, and naïve T cells

Yu, C.; Liu, Y.; Peng, X., 2002:
IL-8 and IL-10 levels in endometriosis and regulated role of neiyifang on them

Fredriksson, M.; Bergström, K.; Asman, B., 2002:
IL-8 and TNF-alpha from peripheral neutrophils and acute-phase proteins in periodontitis

Lango, R.; Anisimowicz, L.; Siebert, J.; Rogowski, J.; Bakowska, A.; Mroziński, P.; Narkiewicz, M., 2001:
IL-8 concentration in coronary sinus blood during early coronary reperfusion after ischemic arrest

Shi, Y.; Hui, Y.; Zhang, X.; Yang, K.; Yu, C., 1997:
IL-8 in experimental proliferative vitreoretiopathy induced by macrophages

Ceyhan, B.B.; Ozgün, S.; Celikel, T.; Yalçin, M.; Koç, M., 1996:
IL-8 in pleural effusion

Ulfman, L.H.; Joosten, D.P.; van der Linden, J.A.; Lammers, J.W.; Zwaginga, J.J.; Koenderman, L., 2000:
IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells

Miyamoto, K.; Matsukawa, A.; Ohkawara, S.; Takagi, K.; Yoshinaga, M., 1998:
IL-8 is involved in homologous TNF alpha-, but not in IL-1 beta-induced neutrophil infiltration in rabbits

Schadendorf; Möller; Algermissen; Worm; Sticherling; Czarnetzki, 1994:
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor

Mantas, C.; Direskeneli, H.; Oz, D.; Yavuz, S.; Akoglu, T., 2000:
IL-8 producing cells in patients with Behçet's disease

Garin, E.H.; Blanchard, D.K.; Matsushima, K.; Djeu, J.Y., 1994:
IL-8 production by peripheral blood mononuclear cells in nephrotic patients

Smith, R.S.; Fedyk, E.R.; Springer, T.A.; Mukaida, N.; Iglewski, B.H.; Phipps, R.P., 2001:
IL-8 production in human lung fibroblasts and epithelial cells activated by the Pseudomonas autoinducer N-3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-kappa B and activator protein-2

Linevsky, J.K.; Pothoulakis, C.; Keates, S.; Warny, M.; Keates, A.C.; Lamont, J.T.; Kelly, C.P., 1998:
IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes

Fierer, J.; Eckmann, L.; Kagnoff, M., 1993:
IL-8 secreted by epithelial cells invaded by bacteria

Leong, S.R.; Lowman, H.B.; Liu, J.; Shire, S.; Deforge, L.E.; Gillece-Castro, B.L.; McDowell, R.; Hébert, C.A., 1997:
IL-8 single-chain homodimers and heterodimers: interactions with chemokine receptors CXCR1, CXCR2, and DARC

Antonelli, M.; Testa, G.; Tritapepe, L.; D'Errico, R.R.; Costa, D.; Giovannelli, L.; Riccioni, L.; Gasparetto, A.; Catena, G., 2000:
IL-8, IL-6 and ICAM-1 in serum of paediatric patients undergoing cardiopulmonary bypass with and without cardiocirculatory arrest

Stassen, M.; Müller, C.; Arnold, M.; Hültner, L.; Klein-Hessling, S.; Neudörfl, C.; Reineke, T.; Serfling, E.; Schmitt, E., 2001:
IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9

Hoyle, G.W.; Brody, A.R., 2001:
IL-9 and lung fibrosis: a Th2 good guy?

Grohmann, U.; Van Snick, J.; Campanile, F.; Silla, S.; Giampietri, A.; Vacca, C.; Renauld, J.C.; Fioretti, M.C.; Puccetti, P., 2001:
IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10

Gibertini, M., 1996:
IL1 beta impairs relational but not procedural rodent learning in a water maze task

Romani, L.; Bistoni, F.; Mencacci, A.; Cenci, E.; Spaccapelo, R.; Puccetti, P., 1995:
IL12 in Candida albicans infections

Tamura, K.; Fukuda, Y.; Sashio, H.; Takeda, N.; Bamba, H.; Kosaka, T.; Fukui, S.; Sawada, K.; Tamura, K.; Satomi, M.; Yamada, T.; Yamamura, T.; Yamamoto, Y.; Furuyama, J-ichi.; Okamura, H.; Shimoyama, T., 2003:
IL18 polymorphism is associated with an increased risk of Crohn's disease

Frankel, A.E.; Fu, T.; Burbage, C.; Chandler, J.; Willingham, M.C.; Tagge, E.P., 1997:
IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor

Ammar, A.; Bertoli, A.M.; Chouaib, S.; Clemenceau, C.; Jasmin, C.; Georgoulias, V., 1993:
IL2-R alpha chain inhibitory factor (p29) produced by HIV-infected macrophages: cell target and mode of action

Puck, J.M., 1996:
IL2RGbase: a database of gamma c-chain defects causing human X-SCID

Rolling, C.; Treton, D.; Pellegrini, S.; Galanaud, P.; Richard, Y., 1996:
IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells

Torres-Galván, M.J.; Quiralte, J.; Pestano, J.J.; Ortega, N.; Blanco, C.; Castillo, R.; Carrillo, T.; Pérez-Aciego, P.; Sánchez-García, F., 2001:
IL4-R1 (5q31-q33) and FcepsilonRI-betaca (11q13) markers and atopy: a case/control study in a spanish population

Anonymous, 1999:
IL: six week femur rehab stay projected: patient deteriorates & dies in nursing home

Anonymous, 2002:
IL: surgeon 'drops scissors' in nurse's hand: glove punctured--suit brought by nurse

Gitelman, D.R., 2003:
ILAB: a program for postexperimental eye movement analysis

Wieser, H.G.; Blume, W.T.; Fish, D.; Goldensohn, E.; Hufnagel, A.; King, D.; Sperling, M.R.; Lüders, H.; Pedley, T.A., 2001:
ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery

Anonymous, 1997:
ILAE Commission Report. The epidemiology of the epilepsies: future directions. International League Against Epilepsy

Anonymous, 1998:
ILAE Commission report. Restrictions for children with epilepsy. Commission of Pediatrics of the ILAE. International League Against Epilepsy

Anonymous, 1996:
ILAE classification of epilepsies: its applicability and practical value of different diagnostic categories. Osservatorio Regionale per L'Epilessia (OREp), Lombardy

Perucca, E.; Arroyo, S.; Baldy-Moulinier, M.; Dulac, O.; Eskasan, E.; Halasz, P.; Kramer, G.; Majkowski, J.; Nikaronova, M.; Tomson, T.; Johannessen, S., 2001:
ILAE commission report: evaluations and awards at the 4th European Congress of Epileptology, Florence, 7-12 October 2000

Reynolds, E.H., 2001:
ILAE/IBE/WHO Global Campaign "out of the shadows": global and regional developments

Swofford, H.J.; Koertner, A.J.; Zemp, F.; Ausdemore, M.; Liu, A.; Salyards, M.J., 2018:
A method for the statistical interpretation of friction ridge skin impression evidence: Method development and validation

Anonymous, 1998:
ILCA's position on the issue of HIV and infant feeding

Chastain, R.M., 1993:
ILCA's position paper statement on HIV

Spangler, A.; Wilson-Clay, B., 1998:
ILCA, IBLCE, and LLLI: distinct missions define breastfeeding organizations

Spangler, A.K., 1996:
ILCA: the past, the present, the future

Kattwinkel, J.; Niermeyer, S.; Nadkarni, V.; Tibballs, J.; Phillips, B.; Zideman, D.; Van Reempts, P.; Osmond, M., 1999:
ILCOR advisory statement: resuscitation of the newly born infant. An advisory statement from the pediatric working group of the International Liaison Committee on Resuscitation

Genzwuerker, H.V.; Isovic, H.; Ellinger, K., 2002:
ILCOR/ERC recommendations for out-of-hospital 12-lead ECG and fibrinolysis are not well adopted at present

Anonymous, 2002:
ILEX oncology acquires CD52 diagnostic rights for Campath

Kern, J.; Gamberger, D.; Sonicki, Z.; Vuletić, S., 1996:
ILLM--inductive learning algorithm as a method for prediction of life expectancy achieving

Anonymous, 1982:
ILO and its population information activities

Anonymous, 1977:
ILO looks at possible methods of controlling world-wide social security health care costs

Grover, N., 2001:
ILO recommends workers' compensation AIDS guidelines

Hofer, M.; Shuker, L., 2000:
ILSI Europe Workshop on Assessing Health Risks From Environmental Exposure to Chemicals: the Example of Drinking Water. Summary Report. International Life Sciences Institute

Solbé, J.; Holt, M.; Calow, P., 2001:
ILSI Europe workshop on Assessing and Controlling Industrial Impacts on the Aquatic Environment: With Reference to Food Processing. International Life Sciences Institute

Rodrigo, C.P.; Van Praagh, E.; Gibney, M.; Sjöström, M., 1999:
ILSI Europe workshop on Diet and Physical Activity--Interactions for Health: summary and conclusions. 22-24 March, 1999 in Chamonix, France. International Life Sciences Institute

Edwards, G.; Savva, S., 2001:
ILSI Europe, the drinks industry, and a conflict of interest undeclared

Shatenstein, S., 2001:
ILSI and the tobacco industry connection

Stanley, J., 2002:
ILSI and the tobacco industry. International Life Sciences Institute

Doll, R., 2001:
ILSI: no attempt to influence

Smucny, J.J., 1998:
IM diclofenac for biliary colic

Dalton, E.; Dragg, L.; MacLean, S., 1996:
IM injection volume limit

Gladding, M., 1995:
IM match continues upward trend in 1995

Sobti, J.C., 1994:
IMA Workshop on 'Medical Ethics and Ethos in Cases of Torture', IMA House, New Delhi, November 25-27, 1994

Jolly, J.G., 1998:
IMA and blood transfusion services in India

Anonymous, 1993:
IMA to conduct training courses in family planning

Herijgers, P.; Flameng, W., 1997:
IMA use in combined valve surgery and coronary artery bypass grafting

Vanden Brink, J., 1991:
IMACS support shift toward enhanced service

Cariaso, M.; Folta, P.; Wagner, M.; Kuczmarski, T.; Lennon, G., 2000:
IMAGEne I: clustering and ranking of I.M.A.G.E. cDNA clones corresponding to known genes

Anonymous, 1995:
IMAP on emergency contraception. Statement developed by the International Medical Advisory Panel to IPPF (IMAP), 1994

Anonymous, 1993:
IMAP statement on Norplant subdermal contraceptive implant system

Anonymous, 1993:
IMAP statement on contraception for women with medical disorders

Anonymous, 1994:
IMAP statement on contraceptive counselling

Anonymous, 1994:
IMAP statement on contraceptive efficacy

Anonymous, 1994:
IMAP statement on emergency contraception

Anonymous, 1995:
IMAP statement on infertility

Anonymous, 1993:
IMAP statement on voluntary surgical contraception (sterilization)

Martín-Baranera, M.; Planas, I.; Palau, J.; Sanz, F., 1995:
IMASIS computer-based medical record project: dealing with the human factor

Sancho, J.J.; Planas, I.; Domènech, D.; Martín-Baranera, M.; Palau, J.; Sanz, F., 1999:
IMASIS. A multicenter hospital information system--experience in Barcelona

Grover, N.K., 1993:
IMC (Amendment) Ordinance 1992

Borfitz, D., 1986:
IMC "positive steps": limit members, expand plans

Herbst, R.S.; Hong, W.Ki., 2002:
IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer

Anonymous, 2002:
IMCAS - International Master Course on Ageing Skin. Paris, January 2001. Proceedings

Anonymous, 1977:
IMCH to carry on - Del Mundo: continued POPCOM aid assured

Anonymous, 1994:
IMCH's training unit looks into the nineties

Ghosh, S., 2000:
IMCI strategy for India

Hartmann, M.; Bogner, L.; Fippel, M.; Scherer, J.; Scherer, S., 2002:
IMCO(++)--a Monte Carlo based IMRT system

Comins, D.L.; Brooks, C.A.; al-awar, R.S.; Goehring, R.R., 2000:
IMDA/retro-Mannich approach to cis-perhydroquinoline Lycopodium alkaloids: asymmetric synthesis of (+)-luciduline

Anonymous, 1997:
IMED/IVAC IMED Gemini series general-purpose infusion pumps disabled by corrosion in protective circuit

Becks, T., 2002:
IMEX--a new knowledge platform for microsystems in medicine

Anonymous, 1994:
IMF / World Bank boards of governors discuss population, migration

Denoon, D.J., 1995:
IMF, World Bank programs hinder AIDS prevention

Tulgan, H.; Butorac, M.; McCue, J.D., 1997:
IMG applicants to a medical residency program

Lefranc, M.P., 1998:
IMGT (ImMunoGeneTics) locus on focus. A new section of Experimental and Clinical Immunogenetics

Lefranc, M-Paule.; Pommié, C.; Ruiz, M.; Giudicelli, Véronique.; Foulquier, E.; Truong, L.; Thouvenin-Contet, Vérie.; Lefranc, Gérard., 2002:
IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains

Giudicelli, V.; Chaume, D.; Bodmer, J.; Müller, W.; Busin, C.; Marsh, S.; Bontrop, R.; Marc, L.; Malik, A.; Lefranc, M.P., 1997:
IMGT, the international ImMunoGeneTics database

Giudicelli, V.; Chaume, D.; Mennessier, G.; Althaus, H.H.; Müller, W.; Bodmer, J.; Malik, A.; Lefranc, M.P., 1999:
IMGT, the international ImMunoGeneTics database: a new design for immunogenetics data access

Robinson, J.; Waller, M.J.; Parham, P.; Bodmer, J.G.; Marsh, S.G., 2000:
IMGT/HLA Database--a sequence database for the human major histocompatibility complex

Giudicelli, V.; Chaume, D.; Lefranc, M.P., 1998:
IMGT/LIGM-DB: a systematized approach for ImMunoGeneTics database coherence and data distribution improvement

Jaklevic, M.C., 1997:
IMGs (international medical graduates) targeted. Residency slot cuts could hit foreign grads hardest

McClain, T.A., 1996:
IMGs and cultural diversity training

Ward, R.D., 1997:
IMGs set goals for AMA section

Rebuzzi, E.; Pannone, A.; Schiavetti, S.; Santoriello, P.; de Nicola, U.; Fancellu, G.; Cau, P.; Gulli, S.; Dordolin, P.; Maniscalco, P.; Morici, F.; Commessatti, M.; Pozzi-Mucelli, M.; Maiorana, C.S.; Bassini, F., 2002:
IMHS clinical experience in the treatment of peritrochanteric fractures. The results of a multicentric Italian study of 981 cases

Ball, M.J., 1990:
IMIA (International Medical Informatics Association): demystifying powerful technologies. Interview by Bill W. Childs

Lorenzi, N.M., 2000:
IMIA Working Group 13: organizational impact of medical informatics

van Gennip, E.M., 2000:
IMIA Working Group 15: technology assessment and quality development in health informatics

Anonymous, 1994:
IMIA/GMDS Working Conference on Health/Medical Informatics Education. Proceedings. Heidelberg/Heilbronn, Germany

Anonymous, 1993:
IMK-B manipulators for implantology. The Micro Mega experience is repeated

Lober, W.B.; Trigg, L.J.; Bliss, D.; Brinkley, J.M., 2002:
IML: An image markup language

Miller, P.L.; Frawley, S.J.; Sayward, F.G.; Yasnoff, W.A.; Duncan, L.; Fleming, D.W., 1996:
IMM/Serve: a rule-based program for childhood immunization

Gebauer, G.; Rieger, M.; Jäger, W.; Lang, N., 1999:
IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors

Maes, L.; Songa, E.B.; Hamers, R., 1993:
IMOL 881, a new trypanocidal compound

Tysall, L.; Stockdale, M.W.; Chadwick, P.R.; Palepou, M-France.I.; Towner, K.J.; Livermore, D.M.; Woodford, N., 2001:
IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK

Nakamura, T.; Shibata, N.; Doi, Y.; Okuda, K.; Nakata, C.; Heijyo, H.; Matsuo, N.; Masuda, M.; Takahashi, H.; Arakawa, Y., 2002:
IMP-1 type metalo-beta-lactamase producing Serratia marcescens strains isolated from blood culture between 1991 to 2000

Tylka, A.J.; Dietrich, W.F., 2001:
IMP-8 observations of the spectra, composition, and variability of solar heavy ions at high energies relevant to manned space missions

Marques, A.F.; Teixeira, N.A.; Gambaretto, C.; Sillero, A.; Sillero, M.A., 1998:
IMP-GMP 5'-nucleotidase from rat brain: activation by polyphosphates

Quaratino, C.P.; Messina, E.; Arduini, A.; Angelini, G.; Spoto, G.; Gizzi, F.; Ruffini, I.; Odorisio, M.; Giacomello, A., 1998:
IMP-dehydrogenase (IMPDH), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), and phosphodiesterases (PDEs) expression during mycophenolic acid (MPA)-induced differentiation in human neuroblastoma cell lines

Griesmacher, A.; Weigel, G.; Seebacher, G.; Müller, M.M., 1998:
IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide

Brotherton, B.G.; Babka, J.C., 1995:
IMPACT CARE: a quality assessment tool that works

Anonymous, 2002:
IMPACT seeks breakthrough improvements in quality

Lenert, L.A.; Michelson, D.; Flowers, C.; Bergen, M.R., 1995:
IMPACT: an object-oriented graphical environment for construction of multimedia patient interviewing software

Williams, B., 2001:
IMPACT: revitalizing TMA's political clout

Schäffer, A.A.; Wolf, Y.I.; Ponting, C.P.; Koonin, E.V.; Aravind, L.; Altschul, S.F., 2000:
IMPALA: matching a protein sequence against a collection of PSI-BLAST-constructed position-specific score matrices

Magnan, S.; Solberg, L.I.; Kottke, T.E.; Nelson, A.F.; Amundson, G.M.; Richards, S.; Reed, M.K., 1998:
IMPROVE: bridge over troubled waters

Young, R.; Snyder, B., 2002:
IMRT (intensity modulated radiation therapy): progress in technology and reimbursement

Clark, C.H.; Mubata, C.D.; Meehan, C.A.; Bidmead, A.M.; Staffurth, J.; Humphreys, M.E.; Dearnaley, D.P., 2002:
IMRT clinical implementation: prostate and pelvic node irradiation using Helios and a 120-leaf multileaf collimator

Cozzi, L.; Fogliata, A., 2002:
IMRT in the treatment of head and neck cancer: is the present already the future?

Snyder, B., 2002:
IMRT update

Partridge, M.; Ebert, M.; Hesse, B.M., 2002:
IMRT verification by three-dimensional dose reconstruction from portal beam measurements

Jack Yang, C.C.; Raben, A.; Carlson, D., 2001:
IMRT: high-definition radiation therapy in a community hospital

McCormack, J., 1995:
IMS America drops Common Category Database project

Anonymous, 1999:
IMS health annual data show expanding pharmaceutical market growth--three-way tie for number one in global pharmaceutical sales

Anonymous, 1999:
IMS set to tackle issues in the new millennium

Anonymous, 1998:
IMS supports name-specific HIV reports

Anonymous, 1997:
IMS survey reflects physicians' concerns, future needs

Anonymous, 2000:
IMS to support Medicare lawsuit

Tercha, L., 1994:
IMS updates HMM med-surg price indexes

Doyle, J.J., 1991:
IMS updates HMM's med-surg indexes

Doyle, J.J., 1990:
IMS updates HMM's pharmacy indexes

Anonymous, 1999:
IMS: raise Medicaid reimbursement

Zhou, X.; Gan, Y.; Xiong, J.; Zhang, D.; Zhao, Q.; Xia, Z., 2018:
A Method for Tooth Model Reconstruction Based on Integration of Multimodal Images

Anonymous, 1996:
IMSystem focuses on continued enhancements to products and services

Anonymous, 1995:
IMSystem set for overhaul that offers multiple options

Anonymous, 1993:
IMSystem starts up with 10 indicators

Anonymous, 1995:
IMSystem will be an option. Performance measurement strategy evolves, offers flexibility

Anonymous, 1979:
IMTEC 012 (Quantor 412) microfiche reader-printer

Patterson, M.K.; Bulard, R.A.; Larsen, C.; Rohrer, M.D., 1995:
IMTEC implants: clinical evaluation of 120 patients: 548 implants

Yost, L.G., 1977:
IMV mount dismounted

Fried, J.L., 1976:
IMV versus assisted ventilation to eliminate work of breathing

Willer, Jürgen.; Noack, N.; Ellwanger, U.; Hoffmann, Jürgen., 2002:
IMZ implants in the treatment of the shortened dental arch in the upper and lower jaws

Weibrich, G.; Gnoth, S.H.; Buch, R.S.; Müller, F.; Loos, A.H.; Wagner, W., 2001:
IMZ-TwinPlus bone implant system--4 years clinical experience

Mabrut, J.Y.; Grandjean, J.P.; Henry, L.; Chappuis, J.P.; Partensky, C.; Barth, X.; Tissot, E., 2002:
IMesenteric and mesocolic cystic lymphangiomas. Diagnostic and therapeutic management

Suresh, G., 1999:
IMpact-RSV Study Group report

Kraft, 1997:
IMx (Abbott) Immunoassay of Insulin: A Practical Alternative to RIA Hyperinsulinemia Identification in Idiopathic Neurootology and Other Hyperinsulin Metabolic Disorders

Anonymous, 1999:
IN MEMORIAM: genevieve gorbman

Anonymous, 2001:
IN medical group making capitation work by carefully adhering to management tenets

Block-Alper, L.; Webster, P.; Zhou, X.; Supeková, L.; Wong, W.Hung.; Schultz, P.G.; Meyer, D.I., 2002:
IN02, a positive regulator of lipid biosynthesis, is essential for the formation of inducible membranes in yeast

Anonymous, 1997:
INA action stops subcontrator's threats to fire RNs. Illinois Nursing Association

Anonymous, 1997:
INA decries state subcontracting of nursing positions

Ennen, K., 1998:
INA house of delegates 74th Biennial Convention, October 23-25, 1997

Trossman, S., 2000:
INA nurses demand measures to combat workplace violence

Anonymous, 1980:
INA proposes HOPE--market-oriented health care program

Anonymous, 1977:
INA to acquire Hospital Affiliates

Kucera, J.; Havránek, V.; Smolík, J.; Schwarz, J.; Veselý, V.; Kugler, J.; Sýkorová, I.; Santroch, J., 2000:
INAA and PIXE of atmospheric and combustion aerosols

Kvicala, J.; Jiránek, V., 2000:
INAA of serum zinc of inhabitants in five regions of the Czech Republic

Arriola, H.; Longoria, L.; Quintero, A.; Guzman, D., 2000:
INAA of trace elements in colorectal cancer patients

Verel, R.; van Beek, J.D.; Meier, B.H., 1999:
INADEQUATE-CR experiments in the solid state

Mu, Y.; Jiao, M.; Zhao, Y.; Lv, J.; Wang, J.; Hao, J.; Zhang, X.; Kong, Q.; Liu, Z., 2018:
A method for tracing exogenous DNA uptake in live spermatozoa and embryos

Angelidis, P.; Anogianakis, G.; Maglavera, S., 1996:
INCLUDE them all

Piekorz; Hocke, 1998:

Sakata, K.; Antonio, B.A.; Mukai, Y.; Nagasaki, H.; Sakai, Y.; Makino, K.; Sasaki, T., 1999:
INE: a rice genome database with an integrated map view

Anonymous, 2002:
INEEL cleanup. Idaho National Engineering and Environmental Laboratory

Kao; Grey, 1998:
INEPT experiments involving quadrupolar nuclei in solids

Fusman; Zeltser; Rotstein; Chapman; Avitzour; Shapira; Eldor; Elkayam; Caspi; Arber; Berliner, 2000:
INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation

Solovyev, V.V.; Salamov, A.A., 1998 :
INFOGENE: a database of known gene structures and predicted genes and proteins in sequences of genome sequencing projects

Brukner, I., 2002:
INGN-201. Introgen Therapeutics

Gopalkrishnan, R., 2003:
INGN-241. Introgen

Hayashi, A.; Shimura, A.; Uchiyama, H.; Nagao, K.; Kuriyama, T., 1993:
INH preventive therapy in Chiba Prefecture--before and after the renewal of the guideline

Hui, R.; Macmillan, R.D.; Kenny, F.S.; Musgrove, E.A.; Blamey, R.W.; Nicholson, R.I.; Robertson, J.F.; Sutherland, R.L., 2000:
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis

Soussi, T.; Larsen, C.J.; Sigaux, F., 1999:
INK4a-ARF (MTS1) or inhibitor of CDK-alternating reading frame (multiple tumor suppressor gene)

Zindy, F.; van Deursen, J.; Grosveld, G.; Sherr, C.J.; Roussel, M.F., 1999:
INK4d-deficient mice are fertile despite testicular atrophy

Citro, G.; Banks, G.; Cooper, G., 1997:
INKBLOT: a neurological diagnostic decision support system integrating causal and anatomical knowledge

Menz, K.; Radomski, N.; Jost, E., 1996:
INMP, a novel intranuclear matrix protein related to the family of intermediate filament-like proteins: molecular cloning and sequence analysis

Hammond, C.L.; Romano, P.; Roe, S.; Tontonoz, P., 1993:
INO2, a regulatory gene in yeast phospholipid biosynthesis, affects nuclear segregation and bud pattern formation

Acevedo, E.; Delgado, G.; Segil, E., 2002:
INPPARES uses Internet to provide Peruvians with sexuality information and counseling

Aronow, D.B.; Ponte, J.M., 1994:
INQUERY: inference net retrieval of encounter notes in an automated medical record

Cembrowski, G.S.; Anderson, P.G.; Steeber, D.G.; Burnett, B.E., 1994:
INR (International Normalized Ratio) reporting of prothrombin time

Wahl, M.J., 1996:
INR and PTR anticoagulation values

Buchan, J., 2003:
INR author speaks out: lack of data inhibits efforts to combat nursing shortages

Boyd, M.R.; Powell, B.J.; Endicott, D.; Lewis, C.C., 2018:
A Method for Tracking Implementation Strategies: An Exemplar Implementing Measurement-Based Care in Community Behavioral Health Clinics

Brigden, M.L.; Johnston, M.J., 1998:
INR reporting in Canadian medical laboratories: an update. Thrombosis Interest Group of Canada

Koertke, H.; Minami, K.; Bairaktaris, A.; Wagner, O.; Koerfer, R., 2000:
INR self-management following mechanical heart valve replacement

Lidstone, V.; Janes, S.; Stross, P., 2000:
INR: Intervals of measurement can safely extend to 14 weeks

Ahmed, S.; Bennett, S.T.; Huxtable, S.J.; Todd, J.A.; Matthews, D.R.; Gough, S.C., 1999:
INS VNTR allelic variation and dynamic insulin secretion in healthy adult non-diabetic Caucasian subjects

Sautory, O., 1987:
INSEE's permanent demographic sample

Lazar, P., 1993:
INSERM and research in neurosurgery

Girot, R., 1996:
INSERM clinical research network on sickle cell anemia: a tool for therapeutic care and research

Eisinger, F.; Alby, N.; Bremond, A.; Dauplat, J.; Espié, M.; Janiaud, P.; Kuttenn, F.; Lebrun, J.P.; Lefranc, J.P.; Pierret, J.; Sobol, H.; Stoppa-Lyonnet, D.; Thouvenin, D.; Tristant, H.; Feingold, J., 1999:
INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer

Eisinger, F.; Alby, N.; Bremond, A.; Dauplat, J.; Espié, M.; Janiaud, P.; Kuttenn, F.; Lebrun, J.P.; Lefranc, J.P.; Pierret, J.; Sobol, H.; Stoppa-Lyonnet, D.; Thouvenin, D.; Tristant, H.; Feingold, J., 1999:
INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer

Iversen, P., 1993:
INSERM/NIH Conference: antisense oligonucleotides and ribonucleases H, September, 1992

Achard, J.M.; Oudart, N.; Aldigier, J.C., 2000:
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study

Brown, M.J.; Castaigne, A.; Ruilope, L.M.; Mancia, G.; Rosenthal, T.; de Leeuw, P.W.; Ebner, F., 1996:
INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment

Schrader, W.T., 1993:
INSIGHT: subunit functions of the steroid/thyroid receptor family

Minsky, B.D.; Pajak, T.F.; Ginsberg, R.J.; Pisansky, T.M.; Martenson, J.; Komaki, R.; Okawara, G.; Rosenthal, S.A.; Kelsen, D.P., 2002:
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

Hulsman, R.L.; Ros, W.J.; Janssen, M.; Winnubst, J.A., 1997:
INTERACT-CANCER. The development and evaluation of a computer-assisted course on communication skills for medical specialists in oncology

Eilbeck, K.; Brass, A.; Paton, N.; Hodgman, C., 2000:
INTERACT: an object oriented protein-protein interaction database

Carcich, T., 1977:
INTERCARE and service

Anonymous, 1996:
INTERFAB '96 in Nuremberg. High expectations were realized

Hamilton, Némie.; Sabroe, I.; Renshaw, S.A., 2018:
A method for transplantation of human HSCs into zebrafish, to replace humanised murine transplantation models

de Jonge, P.; Huyse, F.J.; Stiefel, F.C.; Slaets, J.P.; Gans, R.O., 2001:
INTERMED--a clinical instrument for biopsychosocial assessment

Huyse, F.J.; de Jonge, P.; Lyons, J.S.; Stiefel, F.C.; Slaets, J.P., 1999:
INTERMED: a tool for controlling for confounding variables and designing multimodal treatment

Urquhart, J., 2000:
INTERNAL MEDICINE IN THE 21ST CENTURY: Controlled drug delivery: therapeutic and pharmacological aspects

Torra i Bou, J.E., 1995 :
INTERNET (Y II). Aids to nursing

Schneider, D., 1993:
INTERNET: linking nurses, scholars, libraries

Lawrence, S.V., 1978:
INTERNIST: computer program expressing clinical experience and judgment of a master internist constitutes a unique resource

Cohen, J.; Carlet, J., 1996:
INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group

Small, 1997:
INTRODUCTION. Part 1: Connectionist Models of Lexical Processing

Demuth, C.; Winther-Larsen, A.; Madsen, A.Tranberg.; Meldgaard, P.; Sorensen, B.Sandahl., 2018:
A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations

Duda, M., 1988:
IOC rescinds ban on birth control drug

Nigg, B.M.; Saltin, B., 2002:
IOC-Olympic Prize 2002

Beart, R.W.; Streeter, O.E., 1998:
IOHDR brachytherapy in recurrent or metastatic colorectal carcinoma

Meuwissen, S.G.; Ewe, K.; Gassull, M.A.; Geboes, K.; Jewell, D.; Pallone, F.; Rachmilewitz, D.; Rask-Madsen, J.; Riddell, B.H.; Sandborn, B.J.; Schmuck, M.L., 2000:
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases

Anonymous, 1996:
IOL (intraocular lens) prices may be stabilizing as payment structures, technology undergo changes

Anonymous, 1995:
IOL (intraocular lense) prices continue sliding in the face of competition, vendor consolidation

Anonymous, 2000:
IOL (intraocular lense) prices expected to decline next year

Anonymous, 1998:
IOL (intraocular lenses) prices led by technology, payments

Avins, L.R., 1997:
IOL condensation

Friederg, M.A.; Berler, D.K., 1994:
IOL fixation techniques at keratoplasty

Anonymous, 1997:
IOL prices level off after 3 years